Gene Symbol | Gene ID | Gene Info |
---|---|---|
Foxi1
|
ENSMUSG00000047861.2 | forkhead box I1 |
Foxo1
|
ENSMUSG00000044167.5 | forkhead box O1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_34184426_34184577 | Foxi1 | 23588 | 0.169164 | 0.37 | 5.6e-03 | Click! |
chr11_34181347_34181509 | Foxi1 | 26661 | 0.161413 | -0.31 | 2.1e-02 | Click! |
chr11_34181652_34181837 | Foxi1 | 26345 | 0.162224 | -0.20 | 1.5e-01 | Click! |
chr11_34181851_34182072 | Foxi1 | 26128 | 0.162780 | 0.06 | 6.6e-01 | Click! |
chr3_52268206_52269192 | Foxo1 | 363 | 0.668297 | 0.31 | 2.3e-02 | Click! |
chr3_52257926_52258078 | Foxo1 | 10334 | 0.120734 | -0.26 | 5.4e-02 | Click! |
chr3_52267663_52268126 | Foxo1 | 442 | 0.708756 | 0.15 | 2.7e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_87806707_87807032 | 48.55 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
546 |
0.86 |
chr11_69062573_69063351 | 46.64 |
9330160F10Rik |
RIKEN cDNA 9330160F10 gene |
2479 |
0.1 |
chr8_126609749_126610213 | 42.17 |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
15995 |
0.22 |
chr13_46875476_46875736 | 41.96 |
Gm48250 |
predicted gene, 48250 |
5421 |
0.17 |
chr8_77478972_77479191 | 39.96 |
0610038B21Rik |
RIKEN cDNA 0610038B21 gene |
37975 |
0.13 |
chr8_109584965_109585123 | 38.12 |
Hp |
haptoglobin |
5872 |
0.14 |
chr14_69321815_69322332 | 36.61 |
Gm16677 |
predicted gene, 16677 |
15009 |
0.09 |
chr14_69540059_69540582 | 36.59 |
Gm27174 |
predicted gene 27174 |
15012 |
0.09 |
chr7_135721881_135722214 | 36.23 |
Mki67 |
antigen identified by monoclonal antibody Ki 67 |
5686 |
0.18 |
chr14_75837044_75838069 | 34.30 |
Gm48931 |
predicted gene, 48931 |
3930 |
0.16 |
chr1_40230393_40230707 | 33.57 |
Il1r1 |
interleukin 1 receptor, type I |
5470 |
0.21 |
chr16_90779900_90780106 | 33.22 |
Urb1 |
URB1 ribosome biogenesis 1 homolog (S. cerevisiae) |
7212 |
0.16 |
chr2_119304636_119305204 | 32.72 |
Vps18 |
VPS18 CORVET/HOPS core subunit |
16133 |
0.1 |
chr4_130295074_130295364 | 32.57 |
Fabp3 |
fatty acid binding protein 3, muscle and heart |
13376 |
0.13 |
chr13_111397493_111397892 | 31.81 |
Gm6270 |
predicted gene 6270 |
29012 |
0.14 |
chr8_91331323_91331874 | 31.77 |
Fto |
fat mass and obesity associated |
17984 |
0.13 |
chr16_92399556_92400502 | 31.57 |
Rcan1 |
regulator of calcineurin 1 |
48 |
0.97 |
chr15_73561033_73561396 | 31.40 |
Dennd3 |
DENN/MADD domain containing 3 |
3578 |
0.23 |
chr10_115817172_115817352 | 31.10 |
Tspan8 |
tetraspanin 8 |
9 |
0.99 |
chr4_95385679_95385958 | 30.63 |
Gm29064 |
predicted gene 29064 |
16972 |
0.23 |
chr10_53929806_53929988 | 30.45 |
Man1a |
mannosidase 1, alpha |
47218 |
0.16 |
chr7_143986396_143986550 | 30.09 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
15455 |
0.17 |
chr6_72272236_72272936 | 30.07 |
Sftpb |
surfactant associated protein B |
32024 |
0.11 |
chr7_103825988_103826174 | 30.05 |
Hbb-bs |
hemoglobin, beta adult s chain |
1644 |
0.14 |
chr2_167431166_167431353 | 30.00 |
Slc9a8 |
solute carrier family 9 (sodium/hydrogen exchanger), member 8 |
7140 |
0.18 |
chr14_41007337_41007980 | 29.89 |
Prxl2a |
peroxiredoxin like 2A |
608 |
0.7 |
chr2_119605771_119605947 | 29.88 |
Oip5os1 |
Opa interacting protein 5, opposite strand 1 |
11556 |
0.1 |
chr12_111896884_111897036 | 29.87 |
Ppp1r13b |
protein phosphatase 1, regulatory subunit 13B |
10659 |
0.12 |
chr7_14525378_14525601 | 29.55 |
Obox4-ps2 |
oocyte specific homeobox 4, pseudogene 2 |
4577 |
0.13 |
chr2_6331309_6331868 | 29.22 |
AL845275.1 |
novel protein |
8508 |
0.19 |
chr4_150685197_150685518 | 29.13 |
Gm16079 |
predicted gene 16079 |
6565 |
0.21 |
chr13_35959790_35959969 | 28.48 |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
1040 |
0.4 |
chr5_137530580_137532081 | 28.26 |
Gnb2 |
guanine nucleotide binding protein (G protein), beta 2 |
33 |
0.9 |
chr3_36918411_36918688 | 28.13 |
4932438A13Rik |
RIKEN cDNA 4932438A13 gene |
10401 |
0.23 |
chr2_173736867_173737587 | 28.06 |
Vapb |
vesicle-associated membrane protein, associated protein B and C |
284 |
0.88 |
chr11_90727394_90727734 | 28.05 |
Tom1l1 |
target of myb1-like 1 (chicken) |
39198 |
0.15 |
chr12_103863072_103863984 | 28.00 |
Serpina1a |
serine (or cysteine) peptidase inhibitor, clade A, member 1A |
23 |
0.95 |
chr9_98313593_98313876 | 27.99 |
Gm28530 |
predicted gene 28530 |
12084 |
0.2 |
chr11_76884538_76884711 | 27.91 |
Tmigd1 |
transmembrane and immunoglobulin domain containing 1 |
17535 |
0.16 |
chr2_60940262_60940686 | 27.87 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22718 |
0.21 |
chr13_63564531_63566515 | 27.79 |
Ptch1 |
patched 1 |
212 |
0.91 |
chr19_41495576_41495952 | 27.78 |
Lcor |
ligand dependent nuclear receptor corepressor |
12735 |
0.21 |
chr10_68446597_68447155 | 27.67 |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
78891 |
0.09 |
chr19_47403091_47403290 | 27.30 |
Sh3pxd2a |
SH3 and PX domains 2A |
7169 |
0.23 |
chr8_91379413_91379593 | 27.19 |
Fto |
fat mass and obesity associated |
11052 |
0.15 |
chr1_135731863_135732606 | 27.12 |
Csrp1 |
cysteine and glycine-rich protein 1 |
3087 |
0.22 |
chr19_6300372_6300856 | 26.81 |
Ehd1 |
EH-domain containing 1 |
2700 |
0.11 |
chr7_19547388_19547655 | 26.75 |
Ppp1r37 |
protein phosphatase 1, regulatory subunit 37 |
14539 |
0.08 |
chr7_25477037_25477380 | 26.71 |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 |
326 |
0.82 |
chr1_175607974_175608194 | 26.52 |
Fh1 |
fumarate hydratase 1 |
1437 |
0.39 |
chr9_50692728_50692943 | 26.39 |
Dixdc1 |
DIX domain containing 1 |
964 |
0.45 |
chr15_3247489_3247792 | 26.33 |
Selenop |
selenoprotein P |
20907 |
0.18 |
chr1_184781740_184782518 | 26.21 |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
26724 |
0.12 |
chr8_109865208_109865726 | 25.98 |
Ap1g1 |
adaptor protein complex AP-1, gamma 1 subunit |
2359 |
0.17 |
chr1_166002288_166003185 | 25.93 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr16_11423409_11423900 | 25.80 |
Snx29 |
sorting nexin 29 |
2946 |
0.31 |
chr3_121346684_121346842 | 25.68 |
Gm5711 |
predicted gene 5711 |
33916 |
0.12 |
chr5_139796762_139798525 | 25.54 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
129 |
0.94 |
chr6_120579566_120580923 | 25.30 |
Gm44124 |
predicted gene, 44124 |
68 |
0.96 |
chr6_84640633_84641008 | 25.19 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
46912 |
0.17 |
chr10_69910043_69910940 | 25.14 |
Ank3 |
ankyrin 3, epithelial |
4374 |
0.35 |
chr3_89280469_89281651 | 25.10 |
Efna1 |
ephrin A1 |
82 |
0.91 |
chr13_104037534_104037876 | 25.08 |
Nln |
neurolysin (metallopeptidase M3 family) |
63 |
0.98 |
chr1_162891926_162892449 | 25.05 |
Fmo2 |
flavin containing monooxygenase 2 |
5672 |
0.19 |
chr5_123201506_123201803 | 25.05 |
Gm43409 |
predicted gene 43409 |
10066 |
0.1 |
chr3_100438275_100438426 | 24.95 |
Gm43121 |
predicted gene 43121 |
516 |
0.73 |
chr11_48855844_48857180 | 24.81 |
Gm16170 |
predicted gene 16170 |
3019 |
0.13 |
chr16_95855291_95855553 | 24.81 |
1600002D24Rik |
RIKEN cDNA 1600002D24 gene |
9652 |
0.19 |
chr3_108096711_108096990 | 24.70 |
Gnat2 |
guanine nucleotide binding protein, alpha transducing 2 |
393 |
0.71 |
chr5_17829215_17829531 | 24.16 |
Cd36 |
CD36 molecule |
6323 |
0.32 |
chr4_154121558_154121709 | 24.15 |
Trp73 |
transformation related protein 73 |
5028 |
0.13 |
chr1_179854274_179854595 | 24.05 |
Ahctf1 |
AT hook containing transcription factor 1 |
50754 |
0.12 |
chr16_49839698_49840015 | 24.04 |
Cd47 |
CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
15510 |
0.24 |
chr19_32215250_32215441 | 23.87 |
Sgms1 |
sphingomyelin synthase 1 |
4332 |
0.25 |
chr13_30346944_30347268 | 23.87 |
Agtr1a |
angiotensin II receptor, type 1a |
1565 |
0.41 |
chr1_134426409_134426588 | 23.76 |
Platr1 |
pluripotency associated transcript 1 |
9130 |
0.1 |
chr7_132308529_132308892 | 23.66 |
Gm44891 |
predicted gene 44891 |
5368 |
0.15 |
chr2_73023761_73024098 | 23.57 |
Sp3os |
trans-acting transcription factor 3, opposite strand |
36688 |
0.12 |
chr15_78312445_78312867 | 23.42 |
Csf2rb2 |
colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) |
6935 |
0.12 |
chr8_94899227_94899584 | 23.31 |
Ccdc102a |
coiled-coil domain containing 102A |
18116 |
0.1 |
chr1_58144549_58144718 | 23.28 |
Gm24548 |
predicted gene, 24548 |
10455 |
0.19 |
chr11_20916554_20916845 | 23.26 |
Gm23681 |
predicted gene, 23681 |
21002 |
0.18 |
chr9_64793074_64793409 | 23.24 |
Dennd4a |
DENN/MADD domain containing 4A |
18099 |
0.18 |
chr7_125478687_125478971 | 23.24 |
Nsmce1 |
NSE1 homolog, SMC5-SMC6 complex component |
270 |
0.91 |
chr19_29128301_29128704 | 23.23 |
Mir101b |
microRNA 101b |
6777 |
0.15 |
chr13_119232734_119232969 | 23.21 |
Gm44488 |
predicted gene, 44488 |
36753 |
0.17 |
chr12_70731586_70731875 | 22.88 |
Gm32369 |
predicted gene, 32369 |
49880 |
0.11 |
chr1_132373964_132374532 | 22.85 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
6361 |
0.13 |
chr9_72409226_72409810 | 22.64 |
Gm27255 |
predicted gene 27255 |
250 |
0.55 |
chr5_51039988_51040153 | 22.62 |
Gm40319 |
predicted gene, 40319 |
12311 |
0.29 |
chr6_28232245_28232573 | 22.50 |
Gm42548 |
predicted gene 42548 |
4604 |
0.16 |
chr11_75637667_75638005 | 22.45 |
Inpp5k |
inositol polyphosphate 5-phosphatase K |
1301 |
0.31 |
chr15_98827590_98827953 | 22.44 |
Prkag1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit |
1643 |
0.18 |
chr11_95356789_95356995 | 22.43 |
Fam117a |
family with sequence similarity 117, member A |
16930 |
0.11 |
chr15_83169572_83169952 | 22.30 |
Cyb5r3 |
cytochrome b5 reductase 3 |
415 |
0.72 |
chr18_3839754_3840089 | 22.29 |
Rpl7a-ps6 |
ribosomal protein L7A, pseudogene 6 |
18659 |
0.24 |
chr15_99651541_99652191 | 22.25 |
Racgap1 |
Rac GTPase-activating protein 1 |
210 |
0.88 |
chr8_14889769_14890087 | 22.25 |
Cln8 |
CLN8 transmembrane ER and ERGIC protein |
569 |
0.76 |
chr4_139387042_139387343 | 22.24 |
Ubr4 |
ubiquitin protein ligase E3 component n-recognin 4 |
6523 |
0.12 |
chr8_94354109_94354553 | 22.02 |
Slc12a3 |
solute carrier family 12, member 3 |
715 |
0.52 |
chr14_70712869_70713078 | 21.95 |
Xpo7 |
exportin 7 |
4938 |
0.18 |
chr12_102787968_102788326 | 21.87 |
Gm47042 |
predicted gene, 47042 |
23435 |
0.08 |
chr12_111517954_111518283 | 21.86 |
Gm40578 |
predicted gene, 40578 |
17278 |
0.1 |
chr5_139734496_139734696 | 21.85 |
Micall2 |
MICAL-like 2 |
1740 |
0.28 |
chr5_103620346_103620572 | 21.83 |
Gm15844 |
predicted gene 15844 |
4012 |
0.16 |
chr5_75377761_75377951 | 21.74 |
Gm22084 |
predicted gene, 22084 |
5711 |
0.2 |
chr1_86479174_86479713 | 21.59 |
Rpl30-ps6 |
ribosomal protein L30, pseudogene 6 |
5784 |
0.15 |
chr8_35432677_35432856 | 21.55 |
Gm34853 |
predicted gene, 34853 |
6968 |
0.18 |
chr2_170154042_170154240 | 21.49 |
Zfp217 |
zinc finger protein 217 |
6038 |
0.3 |
chr15_56624074_56624399 | 21.43 |
Has2os |
hyaluronan synthase 2, opposite strand |
65708 |
0.12 |
chr13_52831701_52831898 | 21.35 |
BB123696 |
expressed sequence BB123696 |
74594 |
0.1 |
chr4_139299064_139299339 | 21.29 |
Capzb |
capping protein (actin filament) muscle Z-line, beta |
10255 |
0.1 |
chr3_131283448_131283608 | 21.25 |
Gm18492 |
predicted gene, 18492 |
1616 |
0.31 |
chr1_39068024_39068183 | 21.24 |
Gm37821 |
predicted gene, 37821 |
10466 |
0.18 |
chr11_53483383_53483573 | 21.24 |
Sowaha |
sosondowah ankyrin repeat domain family member A |
3204 |
0.1 |
chr14_14351950_14353283 | 21.02 |
Il3ra |
interleukin 3 receptor, alpha chain |
2995 |
0.15 |
chr4_150784890_150785122 | 20.97 |
Gm13049 |
predicted gene 13049 |
40727 |
0.13 |
chr14_32146198_32146521 | 20.96 |
Msmb |
beta-microseminoprotein |
1228 |
0.33 |
chr8_33734991_33735310 | 20.85 |
Gtf2e2 |
general transcription factor II E, polypeptide 2 (beta subunit) |
1707 |
0.27 |
chr16_38287320_38287555 | 20.84 |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
7387 |
0.15 |
chr2_178662514_178662699 | 20.70 |
Cdh26 |
cadherin-like 26 |
201976 |
0.03 |
chr4_119036598_119036749 | 20.66 |
Gm12866 |
predicted gene 12866 |
32438 |
0.08 |
chr6_72293058_72293242 | 20.59 |
Sftpb |
surfactant associated protein B |
11460 |
0.13 |
chr2_60209324_60210635 | 20.48 |
Marchf7 |
membrane associated ring-CH-type finger 7 |
66 |
0.6 |
chr17_86757763_86757914 | 20.48 |
Epas1 |
endothelial PAS domain protein 1 |
4138 |
0.21 |
chr7_34290925_34291076 | 20.48 |
4931406P16Rik |
RIKEN cDNA 4931406P16 gene |
5401 |
0.13 |
chr8_94180083_94180273 | 20.45 |
Mt1 |
metallothionein 1 |
937 |
0.37 |
chr13_34299446_34299869 | 20.43 |
Gm47086 |
predicted gene, 47086 |
19151 |
0.18 |
chr8_45294810_45294970 | 20.42 |
Klkb1 |
kallikrein B, plasma 1 |
31 |
0.97 |
chr3_129887905_129888104 | 20.34 |
Pla2g12a |
phospholipase A2, group XIIA |
4826 |
0.17 |
chr2_84519488_84520043 | 20.32 |
Gm13710 |
predicted gene 13710 |
11557 |
0.16 |
chr7_50210669_50211262 | 20.29 |
Nell1 |
NEL-like 1 |
112655 |
0.07 |
chr15_77911096_77911448 | 20.22 |
Txn2 |
thioredoxin 2 |
4428 |
0.18 |
chr17_12403367_12403684 | 20.16 |
Plg |
plasminogen |
24866 |
0.14 |
chr15_97004302_97004609 | 20.12 |
Slc38a4 |
solute carrier family 38, member 4 |
15496 |
0.26 |
chr17_84181102_84182153 | 20.04 |
Gm36279 |
predicted gene, 36279 |
4129 |
0.18 |
chr16_92234695_92234852 | 20.04 |
Gm29880 |
predicted gene, 29880 |
27285 |
0.12 |
chr3_57344230_57344525 | 19.98 |
Gm5276 |
predicted gene 5276 |
18011 |
0.19 |
chr10_24948265_24948731 | 19.91 |
Gm36172 |
predicted gene, 36172 |
20879 |
0.13 |
chr2_13523639_13524043 | 19.91 |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
20809 |
0.19 |
chr15_58324072_58324603 | 19.88 |
Klhl38 |
kelch-like 38 |
168 |
0.96 |
chr6_99173700_99173851 | 19.87 |
Foxp1 |
forkhead box P1 |
10757 |
0.29 |
chr12_79674954_79675872 | 19.84 |
9430078K24Rik |
RIKEN cDNA 9430078K24 gene |
249320 |
0.02 |
chr12_79541656_79541860 | 19.80 |
Rad51b |
RAD51 paralog B |
214405 |
0.02 |
chr14_121423066_121423250 | 19.75 |
Gm33299 |
predicted gene, 33299 |
32604 |
0.14 |
chr18_23815450_23815627 | 19.62 |
Gm23207 |
predicted gene, 23207 |
1833 |
0.32 |
chr2_68796050_68796462 | 19.61 |
Gm13612 |
predicted gene 13612 |
34761 |
0.14 |
chr4_134751606_134751882 | 19.59 |
Ldlrap1 |
low density lipoprotein receptor adaptor protein 1 |
894 |
0.61 |
chr18_80260075_80260396 | 19.53 |
Slc66a2 |
solute carrier family 66 member 2 |
2605 |
0.17 |
chrX_169106002_169106405 | 19.45 |
Gm15261 |
predicted gene 15261 |
333 |
0.91 |
chr17_70850487_70852089 | 19.43 |
Tgif1 |
TGFB-induced factor homeobox 1 |
81 |
0.94 |
chr10_85127631_85128502 | 19.42 |
Mterf2 |
mitochondrial transcription termination factor 2 |
39 |
0.97 |
chr13_37537870_37538168 | 19.37 |
Lncbate6 |
brown adipose tissue enriched long noncoding RNA 6 |
3338 |
0.14 |
chr13_9014571_9014768 | 19.37 |
Gtpbp4 |
GTP binding protein 4 |
18586 |
0.1 |
chr13_59795759_59796072 | 19.32 |
Tut7 |
terminal uridylyl transferase 7 |
1215 |
0.28 |
chr17_86313458_86313775 | 19.30 |
2010106C02Rik |
RIKEN cDNA 2010106C02 gene |
26438 |
0.23 |
chr14_7952438_7953164 | 19.28 |
Gm45521 |
predicted gene 45521 |
4487 |
0.21 |
chr13_59832086_59832378 | 19.21 |
Gm34961 |
predicted gene, 34961 |
8966 |
0.11 |
chr11_5009014_5009183 | 19.12 |
Ap1b1 |
adaptor protein complex AP-1, beta 1 subunit |
376 |
0.8 |
chr2_131497603_131497764 | 19.11 |
Smox |
spermine oxidase |
5419 |
0.19 |
chr9_75236923_75237234 | 19.10 |
Myo5c |
myosin VC |
5002 |
0.19 |
chr10_77242950_77243154 | 19.10 |
Pofut2 |
protein O-fucosyltransferase 2 |
16166 |
0.17 |
chr3_89901513_89901736 | 19.01 |
Gm42809 |
predicted gene 42809 |
11292 |
0.11 |
chr1_184060400_184060753 | 18.91 |
Dusp10 |
dual specificity phosphatase 10 |
26195 |
0.19 |
chr10_53383119_53383275 | 18.90 |
Cep85l |
centrosomal protein 85-like |
3250 |
0.17 |
chr17_86523381_86523656 | 18.83 |
Gm10309 |
predicted gene 10309 |
18286 |
0.21 |
chr13_107063669_107063832 | 18.80 |
Gm31452 |
predicted gene, 31452 |
55 |
0.97 |
chr4_35097022_35097220 | 18.79 |
Ifnk |
interferon kappa |
54935 |
0.11 |
chr10_93886358_93886509 | 18.77 |
Metap2 |
methionine aminopeptidase 2 |
1053 |
0.42 |
chr5_32132959_32134082 | 18.62 |
Gm10463 |
predicted gene 10463 |
349 |
0.83 |
chr5_97996482_97996782 | 18.61 |
Antxr2 |
anthrax toxin receptor 2 |
537 |
0.75 |
chr10_93517827_93518213 | 18.59 |
Hal |
histidine ammonia lyase |
16895 |
0.12 |
chr6_83014860_83015022 | 18.57 |
M1ap |
meiosis 1 associated protein |
11397 |
0.07 |
chr8_10866157_10866515 | 18.57 |
Gm32540 |
predicted gene, 32540 |
150 |
0.93 |
chr2_170270298_170270480 | 18.56 |
Gm14270 |
predicted gene 14270 |
14646 |
0.23 |
chr4_130715186_130715488 | 18.55 |
Snord85 |
small nucleolar RNA, C/D box 85 |
34297 |
0.11 |
chr2_72172992_72173245 | 18.53 |
Rapgef4 |
Rap guanine nucleotide exchange factor (GEF) 4 |
6575 |
0.21 |
chr7_112788365_112788757 | 18.51 |
Tead1 |
TEA domain family member 1 |
29015 |
0.19 |
chr4_150007392_150007724 | 18.48 |
H6pd |
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) |
1465 |
0.34 |
chr9_58657759_58658148 | 18.48 |
Rec114 |
REC114 meiotic recombination protein |
1339 |
0.42 |
chr12_110024246_110024718 | 18.47 |
Gm34667 |
predicted gene, 34667 |
609 |
0.65 |
chr9_61370339_61371660 | 18.47 |
Gm10655 |
predicted gene 10655 |
628 |
0.63 |
chr14_70107012_70107367 | 18.44 |
Bin3 |
bridging integrator 3 |
7024 |
0.15 |
chr6_38343722_38344076 | 18.42 |
Zc3hav1 |
zinc finger CCCH type, antiviral 1 |
10374 |
0.13 |
chr15_78413114_78413438 | 18.42 |
Mpst |
mercaptopyruvate sulfurtransferase |
3294 |
0.12 |
chr2_3624075_3624248 | 18.38 |
Fam107b |
family with sequence similarity 107, member B |
10403 |
0.17 |
chr18_80227387_80227553 | 18.36 |
Hsbp1l1 |
heat shock factor binding protein 1-like 1 |
9363 |
0.1 |
chr17_47504772_47505190 | 18.34 |
Ccnd3 |
cyclin D3 |
70 |
0.96 |
chr7_14438643_14438820 | 18.32 |
Sult2a8 |
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 8 |
170 |
0.94 |
chr7_126975552_126976438 | 18.32 |
Cdiptos |
CDIP transferase, opposite strand |
57 |
0.51 |
chr7_64192666_64192825 | 18.31 |
Trpm1 |
transient receptor potential cation channel, subfamily M, member 1 |
6517 |
0.14 |
chr17_47535748_47536285 | 18.30 |
Ccnd3 |
cyclin D3 |
30775 |
0.1 |
chr9_93186720_93187149 | 18.25 |
1700034K08Rik |
RIKEN cDNA 1700034K08 gene |
181195 |
0.03 |
chr19_4559099_4559259 | 18.23 |
Pcx |
pyruvate carboxylase |
369 |
0.82 |
chr2_29677911_29678077 | 18.20 |
Rapgef1 |
Rap guanine nucleotide exchange factor (GEF) 1 |
24488 |
0.15 |
chr6_73232141_73232347 | 18.18 |
Gm40377 |
predicted gene, 40377 |
9194 |
0.17 |
chr6_72104595_72104829 | 18.18 |
Gm29438 |
predicted gene 29438 |
511 |
0.68 |
chr2_167587058_167587564 | 18.17 |
Gm11475 |
predicted gene 11475 |
4084 |
0.14 |
chr11_21079484_21079662 | 18.13 |
Peli1 |
pellino 1 |
11718 |
0.2 |
chr1_170479226_170479433 | 18.08 |
Nos1ap |
nitric oxide synthase 1 (neuronal) adaptor protein |
24415 |
0.21 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.4 | 18.4 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
13.1 | 52.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
13.0 | 39.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
11.9 | 35.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
10.9 | 32.8 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
10.6 | 31.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
10.4 | 52.2 | GO:2000561 | regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
10.4 | 52.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
10.2 | 30.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
9.9 | 29.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
9.6 | 67.2 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
9.5 | 38.2 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
9.3 | 27.8 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
9.2 | 27.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
9.2 | 9.2 | GO:0052041 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
9.1 | 36.6 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
8.5 | 25.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
8.4 | 33.6 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
8.4 | 25.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
8.2 | 24.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
8.0 | 40.0 | GO:0071918 | urea transmembrane transport(GO:0071918) |
7.8 | 23.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
7.7 | 23.0 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
7.7 | 23.0 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
7.4 | 29.6 | GO:0048625 | myoblast fate commitment(GO:0048625) |
7.3 | 22.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
7.3 | 29.4 | GO:0008228 | opsonization(GO:0008228) |
7.2 | 14.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
7.1 | 21.3 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
7.1 | 21.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
7.0 | 21.1 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
6.9 | 41.3 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
6.8 | 20.4 | GO:0009804 | coumarin metabolic process(GO:0009804) |
6.8 | 27.2 | GO:0032264 | IMP salvage(GO:0032264) |
6.7 | 33.4 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
6.5 | 19.5 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
6.5 | 19.4 | GO:0003166 | bundle of His development(GO:0003166) |
6.4 | 25.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
6.4 | 19.3 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
6.4 | 25.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
6.2 | 12.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
6.2 | 18.5 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
6.2 | 18.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
6.2 | 18.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
6.1 | 30.6 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
6.0 | 24.2 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
6.0 | 6.0 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
6.0 | 30.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
5.9 | 35.5 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
5.9 | 29.3 | GO:0070627 | ferrous iron import(GO:0070627) |
5.8 | 5.8 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
5.8 | 17.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
5.8 | 17.3 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
5.8 | 17.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
5.8 | 11.5 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
5.7 | 22.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
5.7 | 17.1 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
5.7 | 17.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
5.7 | 39.6 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
5.6 | 11.3 | GO:1990928 | response to amino acid starvation(GO:1990928) |
5.6 | 28.1 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
5.6 | 16.9 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
5.6 | 33.5 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
5.6 | 33.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
5.5 | 11.0 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
5.5 | 10.9 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
5.4 | 16.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
5.4 | 21.6 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
5.4 | 37.6 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
5.3 | 21.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
5.3 | 42.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
5.3 | 21.3 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
5.3 | 16.0 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
5.3 | 5.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
5.2 | 15.7 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
5.1 | 66.8 | GO:0042730 | fibrinolysis(GO:0042730) |
5.1 | 10.3 | GO:0036215 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
5.1 | 30.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
5.0 | 15.0 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
5.0 | 49.9 | GO:0010226 | response to lithium ion(GO:0010226) |
5.0 | 29.9 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
4.9 | 14.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
4.9 | 19.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
4.8 | 14.5 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
4.8 | 14.5 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
4.8 | 14.5 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
4.8 | 19.3 | GO:0009597 | detection of virus(GO:0009597) |
4.8 | 28.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
4.8 | 47.7 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
4.7 | 23.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
4.7 | 70.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
4.7 | 18.6 | GO:0019532 | oxalate transport(GO:0019532) |
4.7 | 27.9 | GO:0006477 | protein sulfation(GO:0006477) |
4.6 | 13.9 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
4.6 | 4.6 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
4.6 | 4.6 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
4.6 | 9.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
4.6 | 4.6 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
4.6 | 18.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
4.6 | 36.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
4.6 | 9.1 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
4.6 | 9.1 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
4.5 | 4.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
4.5 | 13.5 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
4.5 | 18.0 | GO:1900127 | positive regulation of hyaluronan biosynthetic process(GO:1900127) |
4.5 | 40.4 | GO:0036315 | cellular response to sterol(GO:0036315) |
4.5 | 18.0 | GO:0070836 | caveola assembly(GO:0070836) |
4.5 | 22.4 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
4.5 | 13.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
4.5 | 13.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
4.4 | 13.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
4.4 | 13.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
4.4 | 35.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
4.4 | 22.2 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
4.4 | 4.4 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
4.4 | 17.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
4.4 | 8.7 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
4.4 | 13.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
4.3 | 13.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
4.3 | 13.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
4.3 | 25.8 | GO:0015871 | choline transport(GO:0015871) |
4.3 | 12.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
4.2 | 8.5 | GO:0015793 | glycerol transport(GO:0015793) |
4.2 | 16.9 | GO:0003383 | apical constriction(GO:0003383) |
4.2 | 12.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
4.2 | 12.6 | GO:0002432 | granuloma formation(GO:0002432) |
4.2 | 83.8 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
4.2 | 12.6 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
4.2 | 16.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
4.2 | 20.9 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
4.2 | 4.2 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
4.1 | 16.4 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
4.1 | 8.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
4.1 | 8.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
4.1 | 12.2 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
4.0 | 60.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
4.0 | 12.0 | GO:0080009 | mRNA methylation(GO:0080009) |
4.0 | 12.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
4.0 | 15.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
4.0 | 19.8 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
3.9 | 3.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
3.9 | 35.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
3.9 | 7.9 | GO:0009826 | unidimensional cell growth(GO:0009826) |
3.9 | 11.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
3.9 | 11.7 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.9 | 15.6 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
3.9 | 23.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
3.9 | 15.6 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
3.9 | 11.6 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
3.9 | 15.5 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
3.9 | 3.9 | GO:0060632 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) regulation of microtubule-based movement(GO:0060632) |
3.9 | 15.4 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
3.9 | 11.6 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
3.9 | 3.9 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
3.9 | 15.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
3.9 | 11.6 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
3.8 | 26.9 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
3.8 | 3.8 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
3.8 | 26.9 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
3.8 | 19.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
3.8 | 15.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
3.8 | 11.3 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
3.8 | 11.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
3.8 | 11.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
3.8 | 11.3 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
3.7 | 14.8 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
3.7 | 11.1 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
3.7 | 3.7 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
3.7 | 7.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
3.7 | 11.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
3.7 | 7.4 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
3.7 | 11.0 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
3.7 | 33.0 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
3.7 | 3.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
3.7 | 25.6 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
3.6 | 14.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
3.6 | 29.1 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
3.6 | 3.6 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
3.6 | 14.4 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
3.6 | 3.6 | GO:0070669 | response to interleukin-2(GO:0070669) |
3.6 | 3.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
3.6 | 10.8 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
3.6 | 14.3 | GO:0009092 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
3.6 | 17.9 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
3.6 | 10.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
3.6 | 39.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
3.6 | 71.3 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
3.5 | 10.6 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
3.5 | 14.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
3.5 | 28.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
3.5 | 56.1 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
3.5 | 10.4 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
3.5 | 3.5 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
3.5 | 13.8 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
3.4 | 10.3 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
3.4 | 13.8 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
3.4 | 10.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
3.4 | 10.3 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
3.4 | 27.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
3.4 | 10.3 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
3.4 | 10.2 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) |
3.4 | 6.8 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
3.4 | 20.4 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
3.4 | 13.6 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
3.4 | 17.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
3.4 | 6.8 | GO:1902339 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
3.4 | 16.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
3.4 | 6.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
3.4 | 23.6 | GO:0032782 | bile acid secretion(GO:0032782) |
3.4 | 26.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
3.4 | 13.4 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
3.3 | 73.7 | GO:0006301 | postreplication repair(GO:0006301) |
3.3 | 20.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
3.3 | 20.1 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
3.3 | 3.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
3.3 | 13.4 | GO:0060613 | fat pad development(GO:0060613) |
3.3 | 6.7 | GO:0001705 | ectoderm formation(GO:0001705) |
3.3 | 10.0 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
3.3 | 3.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
3.3 | 10.0 | GO:0015888 | thiamine transport(GO:0015888) |
3.3 | 26.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
3.3 | 10.0 | GO:0015886 | heme transport(GO:0015886) |
3.3 | 13.2 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
3.3 | 3.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
3.3 | 9.9 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
3.3 | 9.8 | GO:0032439 | endosome localization(GO:0032439) |
3.3 | 9.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
3.3 | 9.8 | GO:1902065 | response to L-glutamate(GO:1902065) |
3.2 | 13.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
3.2 | 9.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
3.2 | 12.9 | GO:0045345 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
3.2 | 12.9 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
3.2 | 32.1 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
3.2 | 6.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
3.2 | 31.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
3.2 | 12.6 | GO:0006007 | glucose catabolic process(GO:0006007) |
3.1 | 31.5 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
3.1 | 9.4 | GO:0097167 | circadian regulation of translation(GO:0097167) |
3.1 | 12.5 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
3.1 | 28.0 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
3.1 | 3.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
3.1 | 18.7 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
3.1 | 12.4 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
3.1 | 9.3 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
3.1 | 9.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
3.1 | 18.6 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
3.1 | 3.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
3.1 | 3.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
3.1 | 3.1 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
3.1 | 6.1 | GO:0015819 | lysine transport(GO:0015819) |
3.1 | 15.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
3.1 | 6.1 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
3.1 | 9.2 | GO:0044838 | cell quiescence(GO:0044838) |
3.0 | 3.0 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
3.0 | 15.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
3.0 | 15.2 | GO:0033227 | dsRNA transport(GO:0033227) |
3.0 | 24.3 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
3.0 | 3.0 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
3.0 | 6.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
3.0 | 11.9 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
3.0 | 3.0 | GO:0042746 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
3.0 | 11.8 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
3.0 | 17.7 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
3.0 | 5.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
2.9 | 11.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
2.9 | 11.8 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
2.9 | 5.9 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
2.9 | 8.8 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
2.9 | 8.8 | GO:1903960 | negative regulation of anion transmembrane transport(GO:1903960) |
2.9 | 11.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
2.9 | 14.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
2.9 | 14.5 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
2.9 | 2.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
2.9 | 8.7 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
2.9 | 2.9 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
2.9 | 8.7 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
2.9 | 8.6 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
2.9 | 25.9 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
2.9 | 2.9 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
2.9 | 25.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
2.9 | 5.7 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
2.9 | 8.6 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
2.9 | 8.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
2.9 | 2.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
2.9 | 2.9 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
2.8 | 2.8 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
2.8 | 22.8 | GO:0060896 | neural plate pattern specification(GO:0060896) |
2.8 | 14.2 | GO:0015825 | L-serine transport(GO:0015825) |
2.8 | 5.7 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
2.8 | 56.7 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
2.8 | 19.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
2.8 | 11.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
2.8 | 8.5 | GO:0050904 | diapedesis(GO:0050904) |
2.8 | 8.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
2.8 | 8.4 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
2.8 | 16.8 | GO:0060347 | heart trabecula formation(GO:0060347) |
2.8 | 16.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
2.8 | 14.0 | GO:0019530 | taurine metabolic process(GO:0019530) |
2.8 | 5.6 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
2.8 | 11.1 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
2.8 | 8.3 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
2.8 | 13.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.7 | 8.2 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
2.7 | 11.0 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.7 | 74.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
2.7 | 8.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
2.7 | 5.5 | GO:0072718 | response to cisplatin(GO:0072718) |
2.7 | 8.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.7 | 5.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
2.7 | 21.8 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
2.7 | 8.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
2.7 | 10.9 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
2.7 | 5.4 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
2.7 | 2.7 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
2.7 | 2.7 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
2.7 | 5.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
2.7 | 8.0 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
2.7 | 2.7 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
2.7 | 8.0 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
2.7 | 5.3 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.7 | 5.3 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
2.6 | 10.6 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
2.6 | 7.9 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.6 | 7.9 | GO:0015817 | histidine transport(GO:0015817) |
2.6 | 26.3 | GO:0051014 | actin filament severing(GO:0051014) |
2.6 | 5.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
2.6 | 2.6 | GO:0018904 | ether metabolic process(GO:0018904) |
2.6 | 62.7 | GO:0014823 | response to activity(GO:0014823) |
2.6 | 18.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
2.6 | 28.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
2.6 | 2.6 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
2.6 | 13.0 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
2.6 | 2.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
2.6 | 20.8 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
2.6 | 2.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
2.6 | 2.6 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
2.6 | 12.8 | GO:0015671 | oxygen transport(GO:0015671) |
2.6 | 38.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
2.6 | 5.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.6 | 7.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.6 | 15.4 | GO:0051639 | actin filament network formation(GO:0051639) |
2.6 | 2.6 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
2.6 | 12.8 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
2.6 | 5.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
2.6 | 10.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
2.6 | 10.2 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.5 | 22.9 | GO:0006525 | arginine metabolic process(GO:0006525) |
2.5 | 5.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
2.5 | 12.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
2.5 | 7.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
2.5 | 12.7 | GO:0090399 | replicative senescence(GO:0090399) |
2.5 | 10.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
2.5 | 5.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
2.5 | 7.6 | GO:0090427 | activation of meiosis(GO:0090427) |
2.5 | 7.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
2.5 | 7.6 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
2.5 | 20.2 | GO:0031100 | organ regeneration(GO:0031100) |
2.5 | 15.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
2.5 | 27.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
2.5 | 5.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
2.5 | 5.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
2.5 | 50.1 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
2.5 | 7.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.5 | 12.5 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
2.5 | 2.5 | GO:0010958 | regulation of amino acid import(GO:0010958) |
2.5 | 5.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
2.5 | 22.5 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
2.5 | 5.0 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) |
2.5 | 7.5 | GO:0015867 | ATP transport(GO:0015867) |
2.5 | 7.5 | GO:0090148 | membrane fission(GO:0090148) |
2.5 | 2.5 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
2.5 | 22.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
2.5 | 7.5 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
2.5 | 2.5 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
2.5 | 4.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
2.5 | 7.4 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
2.5 | 7.4 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
2.4 | 7.3 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
2.4 | 7.3 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
2.4 | 12.2 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
2.4 | 34.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.4 | 2.4 | GO:0050872 | white fat cell differentiation(GO:0050872) |
2.4 | 9.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
2.4 | 9.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
2.4 | 9.6 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
2.4 | 4.8 | GO:1901727 | regulation of histone deacetylase activity(GO:1901725) positive regulation of histone deacetylase activity(GO:1901727) |
2.4 | 52.8 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
2.4 | 7.2 | GO:0070254 | mucus secretion(GO:0070254) |
2.4 | 2.4 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
2.4 | 2.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
2.4 | 4.8 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
2.4 | 23.8 | GO:0050779 | RNA destabilization(GO:0050779) |
2.4 | 2.4 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
2.4 | 2.4 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
2.4 | 14.2 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
2.4 | 7.1 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
2.4 | 9.5 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
2.4 | 4.7 | GO:0071895 | odontoblast differentiation(GO:0071895) |
2.4 | 7.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
2.4 | 2.4 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
2.4 | 2.4 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
2.4 | 7.1 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
2.4 | 7.1 | GO:0040031 | snRNA modification(GO:0040031) |
2.4 | 2.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
2.3 | 14.1 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) |
2.3 | 14.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
2.3 | 11.7 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
2.3 | 4.7 | GO:0032898 | neurotrophin production(GO:0032898) |
2.3 | 4.7 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.3 | 2.3 | GO:0008089 | anterograde axonal transport(GO:0008089) |
2.3 | 21.0 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
2.3 | 14.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
2.3 | 18.6 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
2.3 | 67.4 | GO:0006953 | acute-phase response(GO:0006953) |
2.3 | 11.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
2.3 | 2.3 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
2.3 | 9.2 | GO:0046697 | decidualization(GO:0046697) |
2.3 | 4.6 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
2.3 | 6.9 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
2.3 | 4.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
2.3 | 4.6 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
2.3 | 6.9 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
2.3 | 29.7 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
2.3 | 6.9 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.3 | 6.9 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
2.3 | 4.6 | GO:0006901 | vesicle coating(GO:0006901) |
2.3 | 11.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
2.3 | 41.0 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
2.3 | 4.6 | GO:0060596 | mammary placode formation(GO:0060596) |
2.3 | 4.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
2.3 | 15.9 | GO:0032790 | ribosome disassembly(GO:0032790) |
2.3 | 9.1 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
2.3 | 2.3 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
2.3 | 15.9 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
2.3 | 6.8 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
2.3 | 27.1 | GO:0000737 | DNA catabolic process, endonucleolytic(GO:0000737) |
2.3 | 4.5 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
2.3 | 6.8 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
2.2 | 9.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
2.2 | 2.2 | GO:1900193 | regulation of oocyte maturation(GO:1900193) |
2.2 | 4.5 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
2.2 | 31.3 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
2.2 | 8.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
2.2 | 2.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
2.2 | 13.4 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
2.2 | 13.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
2.2 | 2.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
2.2 | 11.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
2.2 | 2.2 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
2.2 | 15.5 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
2.2 | 4.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
2.2 | 13.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
2.2 | 17.6 | GO:0043248 | proteasome assembly(GO:0043248) |
2.2 | 37.2 | GO:0017144 | drug metabolic process(GO:0017144) |
2.2 | 8.8 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
2.2 | 19.7 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
2.2 | 2.2 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
2.2 | 2.2 | GO:0006522 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) |
2.2 | 2.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
2.2 | 4.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
2.2 | 4.3 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
2.1 | 15.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.1 | 10.7 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
2.1 | 15.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
2.1 | 2.1 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
2.1 | 4.3 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
2.1 | 4.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
2.1 | 4.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
2.1 | 8.5 | GO:0010543 | regulation of platelet activation(GO:0010543) |
2.1 | 2.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
2.1 | 6.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
2.1 | 2.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
2.1 | 2.1 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
2.1 | 2.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
2.1 | 12.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
2.1 | 6.3 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
2.1 | 18.9 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
2.1 | 10.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
2.1 | 4.2 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
2.1 | 16.7 | GO:0006544 | glycine metabolic process(GO:0006544) |
2.1 | 22.9 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
2.1 | 6.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
2.1 | 6.2 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
2.1 | 10.3 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
2.1 | 8.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
2.1 | 12.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
2.1 | 6.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
2.1 | 4.1 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
2.0 | 4.1 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
2.0 | 4.1 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
2.0 | 6.1 | GO:0015744 | succinate transport(GO:0015744) |
2.0 | 6.1 | GO:0002894 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
2.0 | 22.5 | GO:0006907 | pinocytosis(GO:0006907) |
2.0 | 8.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
2.0 | 4.1 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
2.0 | 20.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
2.0 | 4.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.0 | 12.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
2.0 | 6.1 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
2.0 | 2.0 | GO:0003164 | His-Purkinje system development(GO:0003164) |
2.0 | 14.2 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
2.0 | 2.0 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
2.0 | 16.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
2.0 | 8.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
2.0 | 6.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.0 | 14.1 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
2.0 | 2.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
2.0 | 16.1 | GO:0033622 | integrin activation(GO:0033622) |
2.0 | 4.0 | GO:0006573 | valine metabolic process(GO:0006573) |
2.0 | 14.1 | GO:0046040 | IMP metabolic process(GO:0046040) |
2.0 | 14.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.0 | 2.0 | GO:0015695 | organic cation transport(GO:0015695) |
2.0 | 14.0 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
2.0 | 2.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.0 | 6.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.0 | 8.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
2.0 | 11.9 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
2.0 | 5.9 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.0 | 2.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
2.0 | 11.8 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
2.0 | 5.9 | GO:0032594 | protein transport within lipid bilayer(GO:0032594) |
2.0 | 2.0 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
2.0 | 15.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
2.0 | 15.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
2.0 | 2.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
2.0 | 5.9 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
2.0 | 13.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
2.0 | 3.9 | GO:0090160 | regulation of natural killer cell degranulation(GO:0043321) Golgi to lysosome transport(GO:0090160) |
1.9 | 5.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
1.9 | 11.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.9 | 3.9 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
1.9 | 5.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.9 | 1.9 | GO:0051255 | spindle midzone assembly(GO:0051255) |
1.9 | 21.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
1.9 | 5.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.9 | 1.9 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
1.9 | 5.8 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.9 | 7.7 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
1.9 | 5.8 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.9 | 5.8 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.9 | 5.8 | GO:0009629 | response to gravity(GO:0009629) |
1.9 | 5.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
1.9 | 11.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
1.9 | 9.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
1.9 | 3.8 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.9 | 9.6 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
1.9 | 7.6 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
1.9 | 11.4 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
1.9 | 17.1 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.9 | 1.9 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
1.9 | 7.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.9 | 5.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
1.9 | 11.4 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.9 | 5.7 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
1.9 | 16.9 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.9 | 7.5 | GO:0048254 | snoRNA localization(GO:0048254) |
1.9 | 9.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.9 | 13.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.9 | 5.6 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.9 | 3.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.9 | 1.9 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
1.9 | 11.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
1.9 | 3.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
1.9 | 3.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.9 | 20.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.8 | 7.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
1.8 | 3.7 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
1.8 | 3.7 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.8 | 7.4 | GO:0033572 | transferrin transport(GO:0033572) |
1.8 | 3.7 | GO:0070827 | chromatin maintenance(GO:0070827) |
1.8 | 9.2 | GO:1902042 | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
1.8 | 5.5 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
1.8 | 1.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
1.8 | 3.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
1.8 | 1.8 | GO:1905048 | regulation of metallopeptidase activity(GO:1905048) |
1.8 | 1.8 | GO:0046878 | positive regulation of saliva secretion(GO:0046878) |
1.8 | 23.6 | GO:0002931 | response to ischemia(GO:0002931) |
1.8 | 7.3 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
1.8 | 3.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.8 | 12.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
1.8 | 7.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.8 | 7.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.8 | 1.8 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.8 | 7.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
1.8 | 1.8 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.8 | 7.2 | GO:0019695 | choline metabolic process(GO:0019695) |
1.8 | 1.8 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.8 | 10.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
1.8 | 1.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.8 | 28.5 | GO:0030488 | tRNA methylation(GO:0030488) |
1.8 | 1.8 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
1.8 | 1.8 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.8 | 3.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
1.8 | 10.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.8 | 1.8 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
1.8 | 1.8 | GO:2000064 | regulation of cortisol biosynthetic process(GO:2000064) |
1.8 | 1.8 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
1.8 | 5.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
1.8 | 5.3 | GO:0021570 | rhombomere 4 development(GO:0021570) |
1.8 | 54.8 | GO:0007569 | cell aging(GO:0007569) |
1.8 | 5.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
1.8 | 8.8 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.8 | 10.6 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.8 | 1.8 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.8 | 3.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
1.8 | 1.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.8 | 8.8 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
1.8 | 22.8 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.7 | 13.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.7 | 7.0 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
1.7 | 7.0 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.7 | 5.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
1.7 | 17.3 | GO:0043486 | histone exchange(GO:0043486) |
1.7 | 3.5 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
1.7 | 5.2 | GO:0009136 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
1.7 | 3.5 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
1.7 | 3.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
1.7 | 3.5 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
1.7 | 8.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
1.7 | 8.6 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
1.7 | 6.9 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
1.7 | 1.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
1.7 | 13.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.7 | 6.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
1.7 | 12.0 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
1.7 | 20.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
1.7 | 3.4 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.7 | 6.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
1.7 | 3.4 | GO:0097066 | response to thyroid hormone(GO:0097066) |
1.7 | 10.2 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.7 | 6.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
1.7 | 17.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.7 | 8.5 | GO:0098814 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
1.7 | 8.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.7 | 23.7 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.7 | 10.1 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.7 | 1.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.7 | 3.4 | GO:0045064 | T-helper 2 cell differentiation(GO:0045064) |
1.7 | 11.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
1.7 | 5.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.7 | 5.0 | GO:0009838 | abscission(GO:0009838) |
1.7 | 5.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.7 | 8.3 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
1.7 | 1.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
1.7 | 1.7 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
1.7 | 3.3 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
1.7 | 1.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.7 | 3.3 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
1.6 | 9.9 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
1.6 | 8.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
1.6 | 4.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.6 | 1.6 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
1.6 | 1.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
1.6 | 4.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.6 | 3.3 | GO:0030242 | pexophagy(GO:0030242) |
1.6 | 1.6 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
1.6 | 21.2 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
1.6 | 6.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
1.6 | 8.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.6 | 9.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.6 | 6.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.6 | 22.7 | GO:0009303 | rRNA transcription(GO:0009303) |
1.6 | 3.2 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
1.6 | 1.6 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
1.6 | 11.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
1.6 | 14.5 | GO:0006337 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
1.6 | 1.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.6 | 1.6 | GO:0006116 | NADH oxidation(GO:0006116) |
1.6 | 3.2 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.6 | 8.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
1.6 | 3.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.6 | 4.8 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
1.6 | 4.8 | GO:0018343 | protein farnesylation(GO:0018343) |
1.6 | 1.6 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
1.6 | 3.2 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
1.6 | 1.6 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
1.6 | 9.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.6 | 4.8 | GO:0001842 | neural fold formation(GO:0001842) |
1.6 | 1.6 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.6 | 12.7 | GO:0033344 | cholesterol efflux(GO:0033344) |
1.6 | 15.8 | GO:0007035 | vacuolar acidification(GO:0007035) |
1.6 | 4.7 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.6 | 4.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.6 | 23.7 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
1.6 | 6.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.6 | 7.9 | GO:0009992 | cellular water homeostasis(GO:0009992) |
1.6 | 7.9 | GO:0030049 | muscle filament sliding(GO:0030049) |
1.6 | 3.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
1.6 | 1.6 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.6 | 6.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
1.6 | 18.8 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
1.6 | 1.6 | GO:0002158 | osteoclast proliferation(GO:0002158) |
1.6 | 6.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.6 | 1.6 | GO:0007398 | ectoderm development(GO:0007398) |
1.6 | 4.7 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.6 | 4.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.6 | 9.4 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.6 | 6.2 | GO:0018101 | protein citrullination(GO:0018101) |
1.6 | 12.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
1.6 | 4.7 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.5 | 9.3 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
1.5 | 7.7 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
1.5 | 3.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.5 | 12.4 | GO:0030575 | nuclear body organization(GO:0030575) |
1.5 | 4.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
1.5 | 4.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.5 | 3.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.5 | 1.5 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
1.5 | 3.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
1.5 | 6.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.5 | 7.7 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
1.5 | 7.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
1.5 | 6.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.5 | 3.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.5 | 1.5 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.5 | 3.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
1.5 | 10.6 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
1.5 | 3.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
1.5 | 1.5 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) regulation of eosinophil degranulation(GO:0043309) |
1.5 | 1.5 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
1.5 | 1.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.5 | 10.5 | GO:2000194 | regulation of female gonad development(GO:2000194) |
1.5 | 3.0 | GO:0001893 | maternal placenta development(GO:0001893) |
1.5 | 4.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.5 | 3.0 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.5 | 16.4 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
1.5 | 16.4 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.5 | 8.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
1.5 | 5.9 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.5 | 8.9 | GO:0033194 | response to hydroperoxide(GO:0033194) |
1.5 | 5.9 | GO:2000209 | regulation of anoikis(GO:2000209) |
1.5 | 5.9 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.5 | 1.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.5 | 7.4 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
1.5 | 4.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.5 | 25.1 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
1.5 | 20.6 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
1.5 | 23.5 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
1.5 | 13.2 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
1.5 | 2.9 | GO:0046061 | dATP catabolic process(GO:0046061) |
1.5 | 61.6 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
1.5 | 2.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
1.5 | 4.4 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.5 | 8.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.5 | 13.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
1.5 | 5.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
1.5 | 7.3 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
1.5 | 5.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.5 | 8.7 | GO:0016556 | mRNA modification(GO:0016556) |
1.5 | 1.5 | GO:0060926 | atrioventricular node development(GO:0003162) cardiac pacemaker cell development(GO:0060926) |
1.5 | 2.9 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
1.5 | 23.2 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
1.4 | 4.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
1.4 | 1.4 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.4 | 2.9 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
1.4 | 5.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
1.4 | 1.4 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
1.4 | 2.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
1.4 | 5.7 | GO:0060023 | soft palate development(GO:0060023) |
1.4 | 4.3 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
1.4 | 30.0 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.4 | 32.8 | GO:1903825 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
1.4 | 5.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.4 | 2.9 | GO:0015889 | cobalamin transport(GO:0015889) |
1.4 | 5.7 | GO:0014857 | regulation of skeletal muscle cell proliferation(GO:0014857) |
1.4 | 7.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
1.4 | 2.8 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
1.4 | 14.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.4 | 1.4 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.4 | 27.0 | GO:0032608 | interferon-beta production(GO:0032608) |
1.4 | 1.4 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.4 | 4.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.4 | 4.2 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
1.4 | 7.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.4 | 4.2 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
1.4 | 11.3 | GO:0021670 | lateral ventricle development(GO:0021670) |
1.4 | 1.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
1.4 | 2.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.4 | 5.6 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
1.4 | 11.2 | GO:0007097 | nuclear migration(GO:0007097) |
1.4 | 7.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.4 | 4.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
1.4 | 1.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
1.4 | 4.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.4 | 1.4 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
1.4 | 4.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
1.4 | 4.2 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.4 | 8.4 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
1.4 | 23.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
1.4 | 4.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.4 | 2.8 | GO:0010390 | histone monoubiquitination(GO:0010390) |
1.4 | 1.4 | GO:0033280 | response to vitamin D(GO:0033280) |
1.4 | 8.3 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.4 | 11.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
1.4 | 1.4 | GO:0060631 | regulation of meiosis I(GO:0060631) |
1.4 | 5.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
1.4 | 2.8 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.4 | 6.9 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.4 | 4.1 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
1.4 | 15.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
1.4 | 8.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
1.4 | 1.4 | GO:0061042 | vascular wound healing(GO:0061042) |
1.4 | 1.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.4 | 5.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
1.4 | 12.3 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
1.4 | 1.4 | GO:0003284 | septum primum development(GO:0003284) |
1.4 | 6.8 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
1.4 | 5.4 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.4 | 19.0 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
1.4 | 1.4 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
1.4 | 1.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
1.4 | 12.2 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.4 | 6.8 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.4 | 5.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.4 | 1.4 | GO:0031280 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) |
1.3 | 37.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.3 | 2.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
1.3 | 1.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.3 | 6.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
1.3 | 2.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.3 | 2.7 | GO:0033762 | response to glucagon(GO:0033762) |
1.3 | 4.0 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
1.3 | 1.3 | GO:0034620 | cellular response to unfolded protein(GO:0034620) |
1.3 | 1.3 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
1.3 | 2.7 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.3 | 1.3 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.3 | 1.3 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
1.3 | 2.7 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
1.3 | 5.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.3 | 8.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.3 | 4.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.3 | 8.0 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
1.3 | 2.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.3 | 2.6 | GO:0032881 | regulation of polysaccharide metabolic process(GO:0032881) |
1.3 | 1.3 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
1.3 | 3.9 | GO:0071404 | response to low-density lipoprotein particle(GO:0055098) cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
1.3 | 10.5 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
1.3 | 2.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
1.3 | 1.3 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
1.3 | 22.3 | GO:0006491 | N-glycan processing(GO:0006491) |
1.3 | 1.3 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
1.3 | 3.9 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
1.3 | 9.2 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
1.3 | 2.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
1.3 | 7.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
1.3 | 3.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.3 | 2.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.3 | 2.6 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.3 | 6.5 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.3 | 2.6 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
1.3 | 3.9 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.3 | 5.2 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
1.3 | 2.6 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
1.3 | 3.9 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
1.3 | 1.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.3 | 10.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.3 | 1.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
1.3 | 35.0 | GO:0030168 | platelet activation(GO:0030168) |
1.3 | 1.3 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
1.3 | 10.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
1.3 | 5.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.3 | 25.9 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
1.3 | 7.7 | GO:0001945 | lymph vessel development(GO:0001945) |
1.3 | 1.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.3 | 2.6 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.3 | 3.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
1.3 | 5.1 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
1.3 | 1.3 | GO:0001781 | neutrophil apoptotic process(GO:0001781) negative regulation of neutrophil apoptotic process(GO:0033030) |
1.3 | 5.1 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
1.3 | 2.5 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
1.3 | 2.5 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
1.3 | 7.6 | GO:0032060 | bleb assembly(GO:0032060) |
1.3 | 3.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.3 | 1.3 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
1.3 | 6.3 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
1.3 | 11.3 | GO:0006183 | GTP biosynthetic process(GO:0006183) |
1.3 | 5.0 | GO:0036003 | positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
1.3 | 5.0 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
1.3 | 2.5 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
1.3 | 5.0 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.3 | 12.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.2 | 17.5 | GO:0046916 | cellular transition metal ion homeostasis(GO:0046916) |
1.2 | 1.2 | GO:0046477 | glucosylceramide catabolic process(GO:0006680) glycosylceramide catabolic process(GO:0046477) |
1.2 | 3.7 | GO:0051452 | intracellular pH reduction(GO:0051452) |
1.2 | 3.7 | GO:0032252 | secretory granule localization(GO:0032252) |
1.2 | 31.1 | GO:1901998 | toxin transport(GO:1901998) |
1.2 | 3.7 | GO:0051775 | response to redox state(GO:0051775) |
1.2 | 7.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
1.2 | 2.5 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.2 | 1.2 | GO:0070339 | response to bacterial lipopeptide(GO:0070339) cellular response to bacterial lipoprotein(GO:0071220) cellular response to bacterial lipopeptide(GO:0071221) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
1.2 | 1.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.2 | 8.7 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.2 | 3.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
1.2 | 2.5 | GO:1904528 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
1.2 | 2.5 | GO:0060426 | lung vasculature development(GO:0060426) |
1.2 | 30.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
1.2 | 3.7 | GO:0042447 | hormone catabolic process(GO:0042447) |
1.2 | 7.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.2 | 2.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
1.2 | 1.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.2 | 3.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
1.2 | 8.6 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
1.2 | 1.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
1.2 | 7.4 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
1.2 | 4.9 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
1.2 | 3.7 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
1.2 | 3.7 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.2 | 3.7 | GO:0043144 | snoRNA processing(GO:0043144) |
1.2 | 2.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.2 | 6.1 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
1.2 | 11.0 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
1.2 | 4.9 | GO:0010039 | response to iron ion(GO:0010039) |
1.2 | 8.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
1.2 | 8.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
1.2 | 53.6 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
1.2 | 2.4 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.2 | 2.4 | GO:0001757 | somite specification(GO:0001757) |
1.2 | 2.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.2 | 8.5 | GO:0006817 | phosphate ion transport(GO:0006817) |
1.2 | 4.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.2 | 1.2 | GO:0070828 | heterochromatin organization(GO:0070828) |
1.2 | 1.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.2 | 2.4 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
1.2 | 4.8 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.2 | 16.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.2 | 3.6 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
1.2 | 2.4 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
1.2 | 1.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
1.2 | 6.0 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
1.2 | 9.5 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
1.2 | 3.6 | GO:0061009 | common bile duct development(GO:0061009) |
1.2 | 1.2 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
1.2 | 1.2 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
1.2 | 3.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
1.2 | 7.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.2 | 1.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
1.2 | 1.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
1.2 | 3.6 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
1.2 | 1.2 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.2 | 4.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
1.2 | 3.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.2 | 20.0 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
1.2 | 2.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
1.2 | 3.5 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.2 | 1.2 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
1.2 | 1.2 | GO:0015884 | folic acid transport(GO:0015884) |
1.2 | 2.3 | GO:2000662 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
1.2 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
1.2 | 1.2 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
1.2 | 10.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
1.2 | 8.1 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) negative regulation of mRNA polyadenylation(GO:1900364) |
1.2 | 1.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.2 | 8.1 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
1.2 | 8.1 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
1.2 | 2.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
1.2 | 8.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
1.2 | 27.7 | GO:0055088 | lipid homeostasis(GO:0055088) |
1.2 | 2.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
1.2 | 1.2 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
1.2 | 1.2 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
1.1 | 1.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
1.1 | 3.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
1.1 | 5.7 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
1.1 | 4.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
1.1 | 2.3 | GO:0034505 | tooth mineralization(GO:0034505) |
1.1 | 3.4 | GO:0043084 | penile erection(GO:0043084) |
1.1 | 9.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.1 | 18.2 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
1.1 | 14.7 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
1.1 | 1.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
1.1 | 2.3 | GO:0043301 | negative regulation of leukocyte degranulation(GO:0043301) |
1.1 | 7.9 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
1.1 | 1.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
1.1 | 2.2 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
1.1 | 4.5 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
1.1 | 2.2 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
1.1 | 4.5 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
1.1 | 3.4 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
1.1 | 2.2 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.1 | 1.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
1.1 | 4.5 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.1 | 4.5 | GO:0046688 | response to copper ion(GO:0046688) |
1.1 | 3.3 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
1.1 | 11.1 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
1.1 | 2.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.1 | 3.3 | GO:0007525 | somatic muscle development(GO:0007525) |
1.1 | 3.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.1 | 1.1 | GO:0061512 | protein localization to cilium(GO:0061512) |
1.1 | 4.4 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
1.1 | 6.6 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
1.1 | 18.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.1 | 1.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.1 | 1.1 | GO:0035646 | endosome to melanosome transport(GO:0035646) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
1.1 | 17.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
1.1 | 3.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.1 | 9.7 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
1.1 | 4.3 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
1.1 | 2.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
1.1 | 3.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
1.1 | 2.1 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
1.1 | 5.3 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.1 | 1.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
1.1 | 3.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
1.1 | 4.2 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.1 | 1.1 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
1.1 | 7.4 | GO:0002115 | store-operated calcium entry(GO:0002115) |
1.1 | 10.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.1 | 45.2 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
1.1 | 1.1 | GO:0032366 | intracellular sterol transport(GO:0032366) |
1.0 | 37.8 | GO:0007599 | hemostasis(GO:0007599) |
1.0 | 3.1 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.0 | 4.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.0 | 8.4 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
1.0 | 3.1 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
1.0 | 39.6 | GO:0043038 | amino acid activation(GO:0043038) |
1.0 | 4.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.0 | 4.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
1.0 | 27.1 | GO:0006956 | complement activation(GO:0006956) |
1.0 | 3.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
1.0 | 3.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.0 | 7.2 | GO:0051382 | kinetochore assembly(GO:0051382) |
1.0 | 2.1 | GO:0001845 | phagolysosome assembly(GO:0001845) |
1.0 | 5.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.0 | 6.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
1.0 | 3.0 | GO:0007602 | phototransduction(GO:0007602) |
1.0 | 2.0 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
1.0 | 6.1 | GO:0030261 | chromosome condensation(GO:0030261) |
1.0 | 3.0 | GO:0072676 | lymphocyte migration(GO:0072676) |
1.0 | 5.0 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.0 | 6.0 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
1.0 | 9.1 | GO:0007141 | male meiosis I(GO:0007141) |
1.0 | 7.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
1.0 | 3.0 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
1.0 | 4.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
1.0 | 1.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
1.0 | 5.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.0 | 9.0 | GO:0070633 | transepithelial transport(GO:0070633) |
1.0 | 21.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
1.0 | 2.0 | GO:0000255 | allantoin metabolic process(GO:0000255) |
1.0 | 4.0 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.0 | 3.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.0 | 1.0 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
1.0 | 15.7 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
1.0 | 2.9 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
1.0 | 2.9 | GO:0060770 | epithelial cell proliferation involved in prostate gland development(GO:0060767) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.0 | 11.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
1.0 | 10.7 | GO:0007099 | centriole replication(GO:0007099) |
1.0 | 3.9 | GO:0006312 | mitotic recombination(GO:0006312) |
1.0 | 1.0 | GO:0048819 | regulation of hair follicle maturation(GO:0048819) |
1.0 | 3.9 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
1.0 | 3.9 | GO:0016266 | O-glycan processing(GO:0016266) |
1.0 | 7.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.0 | 1.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
1.0 | 1.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.0 | 1.9 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
1.0 | 1.0 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
1.0 | 1.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
1.0 | 8.6 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
1.0 | 32.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
1.0 | 1.0 | GO:0010046 | response to mycotoxin(GO:0010046) |
1.0 | 3.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.0 | 4.8 | GO:0046037 | GMP metabolic process(GO:0046037) |
1.0 | 3.8 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
1.0 | 4.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.0 | 5.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.9 | 3.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.9 | 4.7 | GO:0032095 | regulation of response to food(GO:0032095) |
0.9 | 4.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.9 | 10.4 | GO:0002687 | positive regulation of leukocyte migration(GO:0002687) |
0.9 | 2.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.9 | 7.6 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.9 | 2.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.9 | 0.9 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.9 | 1.9 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.9 | 3.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.9 | 13.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.9 | 0.9 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.9 | 6.5 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.9 | 8.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.9 | 11.2 | GO:0035825 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.9 | 1.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.9 | 1.9 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.9 | 5.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.9 | 1.9 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.9 | 1.9 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.9 | 0.9 | GO:0072337 | modified amino acid transport(GO:0072337) |
0.9 | 0.9 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.9 | 1.8 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.9 | 9.2 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.9 | 2.8 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.9 | 2.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
0.9 | 4.6 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.9 | 0.9 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.9 | 7.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.9 | 5.5 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.9 | 7.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.9 | 3.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.9 | 0.9 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.9 | 1.8 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.9 | 2.7 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
0.9 | 2.7 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.9 | 28.1 | GO:0009060 | aerobic respiration(GO:0009060) |
0.9 | 11.7 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.9 | 3.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.9 | 2.7 | GO:0002784 | regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.9 | 7.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.9 | 6.3 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
0.9 | 1.8 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.9 | 10.7 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.9 | 7.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.9 | 3.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.9 | 0.9 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
0.9 | 1.8 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.9 | 0.9 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.9 | 1.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.9 | 1.8 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.9 | 2.6 | GO:0007343 | egg activation(GO:0007343) |
0.9 | 1.8 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.9 | 1.8 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.9 | 1.8 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.9 | 0.9 | GO:0032094 | response to food(GO:0032094) |
0.9 | 13.1 | GO:0016180 | snRNA processing(GO:0016180) |
0.9 | 0.9 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.9 | 6.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.9 | 1.7 | GO:2000318 | regulation of T-helper 17 type immune response(GO:2000316) positive regulation of T-helper 17 type immune response(GO:2000318) |
0.9 | 7.9 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.9 | 0.9 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.9 | 6.9 | GO:0002347 | response to tumor cell(GO:0002347) |
0.9 | 4.3 | GO:0046110 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.9 | 2.6 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.9 | 2.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 4.3 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.9 | 3.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.9 | 0.9 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.9 | 1.7 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.9 | 2.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.9 | 4.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.9 | 2.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.9 | 1.7 | GO:1903541 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.8 | 5.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.8 | 2.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.8 | 5.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.8 | 4.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.8 | 0.8 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.8 | 2.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.8 | 11.0 | GO:0046854 | lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
0.8 | 2.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 1.7 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.8 | 11.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.8 | 4.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.8 | 0.8 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.8 | 3.3 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.8 | 1.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.8 | 13.3 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.8 | 1.7 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.8 | 14.1 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.8 | 1.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.8 | 0.8 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.8 | 29.8 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.8 | 1.7 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.8 | 21.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.8 | 0.8 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.8 | 0.8 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.8 | 4.9 | GO:0031648 | protein destabilization(GO:0031648) |
0.8 | 4.9 | GO:0015807 | L-amino acid transport(GO:0015807) |
0.8 | 0.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.8 | 45.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.8 | 1.6 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.8 | 10.6 | GO:0046364 | monosaccharide biosynthetic process(GO:0046364) |
0.8 | 3.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.8 | 8.1 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.8 | 1.6 | GO:0002215 | defense response to nematode(GO:0002215) |
0.8 | 1.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.8 | 0.8 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.8 | 0.8 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.8 | 0.8 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.8 | 9.7 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.8 | 3.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.8 | 8.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.8 | 0.8 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.8 | 8.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.8 | 2.4 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.8 | 2.4 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.8 | 2.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.8 | 0.8 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.8 | 6.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.8 | 0.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.8 | 1.6 | GO:0035087 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.8 | 2.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.8 | 8.7 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.8 | 3.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.8 | 2.4 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.8 | 1.6 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.8 | 0.8 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) cell surface pattern recognition receptor signaling pathway(GO:0002752) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
0.8 | 3.9 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.8 | 4.7 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.8 | 4.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.8 | 0.8 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.8 | 3.1 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.8 | 2.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.8 | 3.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 0.8 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.8 | 2.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.8 | 2.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.8 | 0.8 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.8 | 0.8 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.8 | 1.5 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.8 | 3.9 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.8 | 0.8 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
0.8 | 1.5 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.8 | 3.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.8 | 6.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.8 | 16.9 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.8 | 4.6 | GO:0032418 | lysosome localization(GO:0032418) |
0.8 | 3.8 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.8 | 4.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.8 | 0.8 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.8 | 1.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) positive regulation of plasminogen activation(GO:0010756) |
0.8 | 2.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.8 | 1.5 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.8 | 2.3 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.8 | 3.8 | GO:0071312 | cellular response to alkaloid(GO:0071312) |
0.8 | 8.4 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.8 | 22.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.8 | 0.8 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.8 | 1.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.8 | 2.3 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.8 | 1.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.8 | 0.8 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.8 | 55.5 | GO:0006869 | lipid transport(GO:0006869) |
0.7 | 13.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.7 | 12.0 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.7 | 0.7 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.7 | 0.7 | GO:0045404 | positive regulation of interleukin-4 production(GO:0032753) interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.7 | 0.7 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.7 | 3.0 | GO:0032098 | regulation of appetite(GO:0032098) |
0.7 | 1.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.7 | 2.2 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.7 | 8.9 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.7 | 3.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.7 | 2.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.7 | 1.5 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.7 | 0.7 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.7 | 2.2 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.7 | 2.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.7 | 139.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.7 | 1.5 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.7 | 5.8 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.7 | 0.7 | GO:0019042 | viral latency(GO:0019042) |
0.7 | 3.6 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.7 | 1.4 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.7 | 6.5 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.7 | 0.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.7 | 16.5 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.7 | 7.9 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.7 | 16.5 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.7 | 2.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.7 | 1.4 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.7 | 44.3 | GO:0006457 | protein folding(GO:0006457) |
0.7 | 0.7 | GO:0048293 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.7 | 17.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.7 | 31.3 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.7 | 2.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.7 | 0.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.7 | 4.3 | GO:1904018 | positive regulation of vasculature development(GO:1904018) |
0.7 | 2.8 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.7 | 5.0 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.7 | 4.2 | GO:0000338 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.7 | 2.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.7 | 2.1 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.7 | 0.7 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.7 | 1.4 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.7 | 2.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.7 | 1.4 | GO:0051299 | centrosome separation(GO:0051299) |
0.7 | 0.7 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.7 | 4.2 | GO:0010712 | regulation of collagen metabolic process(GO:0010712) |
0.7 | 11.1 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.7 | 0.7 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.7 | 2.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.7 | 5.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.7 | 2.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.7 | 0.7 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.7 | 4.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.7 | 0.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.7 | 0.7 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.7 | 0.7 | GO:0032239 | regulation of nucleobase-containing compound transport(GO:0032239) regulation of RNA export from nucleus(GO:0046831) |
0.7 | 2.1 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.7 | 1.4 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 3.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.7 | 6.8 | GO:2000045 | regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.7 | 0.7 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.7 | 4.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.7 | 3.4 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.7 | 4.0 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.7 | 1.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.7 | 3.4 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
0.7 | 1.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.7 | 4.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.7 | 2.0 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.7 | 4.0 | GO:0042516 | regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
0.7 | 2.0 | GO:0043297 | apical junction assembly(GO:0043297) |
0.7 | 4.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.7 | 3.3 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.7 | 2.0 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
0.7 | 0.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 1.3 | GO:0006778 | porphyrin-containing compound metabolic process(GO:0006778) |
0.7 | 15.1 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.7 | 2.6 | GO:0030042 | actin filament depolymerization(GO:0030042) |
0.7 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.7 | 6.6 | GO:0045116 | protein neddylation(GO:0045116) |
0.7 | 2.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.7 | 1.3 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.7 | 5.2 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.7 | 0.7 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.7 | 14.3 | GO:0042157 | lipoprotein metabolic process(GO:0042157) |
0.6 | 1.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.6 | 5.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.6 | 0.6 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.6 | 4.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.6 | 3.2 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.6 | 4.5 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.6 | 3.9 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.6 | 3.9 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.6 | 9.6 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.6 | 25.7 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.6 | 12.2 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.6 | 1.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.6 | 0.6 | GO:0043300 | regulation of leukocyte degranulation(GO:0043300) |
0.6 | 0.6 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.6 | 1.3 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.6 | 0.6 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.6 | 3.2 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.6 | 1.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.6 | 1.3 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.6 | 12.5 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.6 | 7.5 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.6 | 0.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.6 | 1.2 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.6 | 0.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.6 | 1.9 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.6 | 1.9 | GO:0071467 | cellular response to pH(GO:0071467) |
0.6 | 0.6 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.6 | 1.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.6 | 1.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.6 | 2.5 | GO:0030595 | leukocyte chemotaxis(GO:0030595) |
0.6 | 2.5 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.6 | 0.6 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.6 | 1.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 2.5 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.6 | 0.6 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.6 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.6 | 0.6 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.6 | 0.6 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.6 | 3.7 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 5.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.6 | 1.8 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.6 | 0.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 1.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.6 | 3.0 | GO:0051013 | microtubule severing(GO:0051013) |
0.6 | 3.6 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.6 | 6.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.6 | 3.6 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.6 | 0.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.6 | 0.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.6 | 0.6 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.6 | 7.7 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.6 | 1.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.6 | 1.8 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.6 | 3.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.6 | 1.2 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.6 | 0.6 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.6 | 4.7 | GO:0043462 | regulation of ATPase activity(GO:0043462) |
0.6 | 1.8 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.6 | 1.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.6 | 17.0 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.6 | 0.6 | GO:0009223 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.6 | 2.3 | GO:0050832 | defense response to fungus(GO:0050832) |
0.6 | 0.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.6 | 2.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.6 | 0.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 2.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.6 | 1.7 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.6 | 9.8 | GO:1903845 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.6 | 4.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.6 | 1.1 | GO:0031639 | plasminogen activation(GO:0031639) |
0.6 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.6 | 26.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 0.6 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
0.6 | 3.4 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.6 | 0.6 | GO:0075733 | transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.6 | 55.1 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.6 | 1.7 | GO:0019359 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
0.6 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.6 | 0.6 | GO:0006900 | membrane budding(GO:0006900) |
0.6 | 2.8 | GO:0048730 | hair follicle morphogenesis(GO:0031069) epidermis morphogenesis(GO:0048730) |
0.6 | 0.6 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.6 | 0.6 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.6 | 1.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.6 | 12.8 | GO:0003281 | ventricular septum development(GO:0003281) |
0.6 | 0.6 | GO:0061097 | regulation of protein tyrosine kinase activity(GO:0061097) |
0.6 | 3.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.6 | 1.7 | GO:0070542 | response to fatty acid(GO:0070542) |
0.6 | 2.2 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.6 | 1.1 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.6 | 1.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.6 | 0.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.5 | 2.2 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.5 | 3.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.5 | 0.5 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.5 | 0.5 | GO:0042181 | ketone biosynthetic process(GO:0042181) |
0.5 | 0.5 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.5 | 2.7 | GO:0060438 | trachea development(GO:0060438) |
0.5 | 0.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 2.7 | GO:0051875 | pigment granule localization(GO:0051875) |
0.5 | 2.7 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.5 | 9.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 10.2 | GO:0006284 | base-excision repair(GO:0006284) |
0.5 | 5.4 | GO:0016575 | histone deacetylation(GO:0016575) |
0.5 | 1.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.5 | 2.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.5 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.5 | 0.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.5 | 2.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.5 | 1.1 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.5 | 0.5 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.5 | 0.5 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.5 | 4.7 | GO:0090305 | nucleic acid phosphodiester bond hydrolysis(GO:0090305) |
0.5 | 2.6 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.5 | 1.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 1.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.5 | 0.5 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.5 | 1.5 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 0.5 | GO:2000514 | regulation of CD4-positive, alpha-beta T cell activation(GO:2000514) |
0.5 | 5.1 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 0.5 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 1.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.5 | 1.0 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.5 | 6.1 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.5 | 2.5 | GO:0072528 | pyrimidine-containing compound biosynthetic process(GO:0072528) |
0.5 | 0.5 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.5 | 8.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.5 | 4.5 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.5 | 0.5 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.5 | 3.5 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.5 | 6.9 | GO:0045453 | bone resorption(GO:0045453) |
0.5 | 9.4 | GO:0001892 | embryonic placenta development(GO:0001892) |
0.5 | 0.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.5 | 0.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.5 | 1.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.5 | 2.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 3.4 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.5 | 7.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.5 | 0.5 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.5 | 4.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 1.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 29.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.5 | 0.5 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 5.7 | GO:0019835 | cytolysis(GO:0019835) |
0.5 | 1.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.5 | 0.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.5 | 0.5 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.5 | 2.8 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.5 | 0.5 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 1.9 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.5 | 0.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.5 | 0.5 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.5 | 1.4 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.5 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.5 | 1.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.5 | 18.9 | GO:0007051 | spindle organization(GO:0007051) |
0.5 | 1.4 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.5 | 1.4 | GO:0098801 | regulation of renal system process(GO:0098801) |
0.5 | 1.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 0.5 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.5 | 0.9 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.5 | 2.7 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.5 | 1.4 | GO:0040029 | regulation of gene expression, epigenetic(GO:0040029) |
0.5 | 0.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.5 | 0.5 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.5 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 0.4 | GO:0070318 | G0 to G1 transition(GO:0045023) regulation of G0 to G1 transition(GO:0070316) positive regulation of G0 to G1 transition(GO:0070318) |
0.4 | 0.9 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.4 | 0.4 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.4 | 0.9 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.4 | 1.8 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.4 | 3.1 | GO:0051693 | actin filament capping(GO:0051693) |
0.4 | 1.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.4 | 0.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.4 | 1.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 32.6 | GO:0051607 | defense response to virus(GO:0051607) |
0.4 | 0.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.4 | 3.9 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.4 | 2.2 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.4 | 2.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.4 | 0.9 | GO:0032490 | detection of molecule of bacterial origin(GO:0032490) |
0.4 | 0.4 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
0.4 | 0.9 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.4 | 0.4 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.4 | 1.7 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 7.3 | GO:0052547 | regulation of peptidase activity(GO:0052547) |
0.4 | 0.4 | GO:0060022 | hard palate development(GO:0060022) |
0.4 | 0.9 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.4 | 0.4 | GO:0033865 | nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.4 | 0.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 1.7 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.4 | 0.4 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
0.4 | 5.9 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.4 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.4 | 0.4 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 1.7 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.4 | 1.3 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.4 | 6.6 | GO:0007566 | embryo implantation(GO:0007566) |
0.4 | 0.8 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.4 | 0.4 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 8.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.4 | 2.9 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.4 | 3.3 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.4 | 4.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.4 | 0.4 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 0.4 | GO:0002715 | regulation of natural killer cell mediated immunity(GO:0002715) |
0.4 | 0.4 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.4 | 1.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.4 | 0.4 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.4 | 0.4 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 1.2 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.4 | 5.6 | GO:0016052 | carbohydrate catabolic process(GO:0016052) |
0.4 | 9.5 | GO:0015758 | glucose transport(GO:0015758) |
0.4 | 29.6 | GO:0032496 | response to lipopolysaccharide(GO:0032496) |
0.4 | 0.4 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.4 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 2.0 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.4 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.4 | 17.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.4 | 0.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.4 | 2.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.4 | 0.4 | GO:0021578 | hindbrain maturation(GO:0021578) pons maturation(GO:0021586) central nervous system maturation(GO:0021626) |
0.4 | 0.8 | GO:0010659 | cardiac muscle cell apoptotic process(GO:0010659) |
0.4 | 12.7 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.4 | 1.2 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.4 | 2.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.4 | 0.8 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.4 | 8.0 | GO:0001824 | blastocyst development(GO:0001824) |
0.4 | 0.8 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.4 | 0.8 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 5.7 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.4 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.4 | 4.1 | GO:0052696 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.4 | 0.4 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) |
0.4 | 4.5 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.4 | 0.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.4 | 1.5 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.4 | 4.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.4 | 1.5 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.4 | 0.4 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.4 | 1.5 | GO:0019915 | lipid storage(GO:0019915) |
0.4 | 4.7 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.4 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 1.5 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.4 | 0.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.4 | 0.4 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.4 | 0.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.4 | 1.8 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.4 | 0.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.4 | 2.5 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.4 | 1.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.4 | 1.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.4 | 7.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.3 | 0.3 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.3 | 0.3 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 2.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.3 | 0.7 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.3 | 2.7 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.3 | 2.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.3 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.3 | 0.7 | GO:0043276 | anoikis(GO:0043276) |
0.3 | 1.4 | GO:0016101 | diterpenoid metabolic process(GO:0016101) |
0.3 | 0.3 | GO:0070555 | response to interleukin-1(GO:0070555) |
0.3 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.3 | 0.3 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.3 | 1.0 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.3 | 1.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.3 | 0.3 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.3 | 1.3 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.3 | 4.1 | GO:0051168 | nuclear export(GO:0051168) |
0.3 | 4.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 0.3 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 0.6 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.3 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 0.9 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.3 | 0.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.3 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 0.9 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.3 | 1.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.3 | 0.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.3 | 25.1 | GO:0032259 | methylation(GO:0032259) |
0.3 | 0.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 7.2 | GO:0008033 | tRNA processing(GO:0008033) |
0.3 | 0.6 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.3 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 1.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.3 | 0.9 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.3 | 1.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.3 | 2.9 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.3 | 0.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.3 | 2.0 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.3 | 4.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 11.0 | GO:0006310 | DNA recombination(GO:0006310) |
0.3 | 0.6 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 2.0 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.3 | 2.0 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 0.3 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 1.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 0.3 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.3 | 0.3 | GO:0002712 | regulation of B cell mediated immunity(GO:0002712) regulation of immunoglobulin mediated immune response(GO:0002889) |
0.3 | 1.4 | GO:1901983 | regulation of histone acetylation(GO:0035065) regulation of protein acetylation(GO:1901983) |
0.3 | 2.7 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.3 | 2.7 | GO:0097484 | dendrite extension(GO:0097484) |
0.3 | 0.3 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.3 | 4.6 | GO:0042060 | wound healing(GO:0042060) |
0.3 | 1.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.3 | 2.7 | GO:0030816 | positive regulation of cAMP metabolic process(GO:0030816) |
0.3 | 0.3 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 1.0 | GO:0043153 | photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
0.3 | 0.5 | GO:0030220 | platelet formation(GO:0030220) |
0.3 | 49.3 | GO:0048232 | male gamete generation(GO:0048232) |
0.3 | 2.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 1.0 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.3 | 2.3 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.3 | 22.8 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.3 | 1.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.3 | 1.0 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 0.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 2.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.2 | 1.5 | GO:1901186 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.2 | 0.2 | GO:0031341 | regulation of cell killing(GO:0031341) |
0.2 | 1.9 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.2 | 0.5 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.2 | 1.2 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.2 | 1.2 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.2 | 0.2 | GO:0033059 | melanosome organization(GO:0032438) cellular pigmentation(GO:0033059) positive regulation of melanin biosynthetic process(GO:0048023) pigment granule organization(GO:0048753) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.2 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
0.2 | 0.2 | GO:0048102 | autophagic cell death(GO:0048102) |
0.2 | 0.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.2 | GO:0051132 | NK T cell activation(GO:0051132) |
0.2 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.2 | 0.2 | GO:0007379 | segment specification(GO:0007379) |
0.2 | 51.7 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.2 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.2 | 3.1 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 1.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.9 | GO:0051180 | vitamin transport(GO:0051180) |
0.2 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 1.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.2 | 1.5 | GO:0045214 | sarcomere organization(GO:0045214) |
0.2 | 0.8 | GO:0097186 | amelogenesis(GO:0097186) |
0.2 | 1.5 | GO:0006342 | chromatin silencing(GO:0006342) |
0.2 | 1.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.2 | 1.9 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.2 | 1.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 0.8 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.2 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.2 | 0.2 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.2 | 0.2 | GO:0036230 | granulocyte activation(GO:0036230) |
0.2 | 2.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.2 | 0.2 | GO:0070988 | demethylation(GO:0070988) |
0.2 | 0.4 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.2 | 1.1 | GO:0035690 | cellular response to drug(GO:0035690) |
0.2 | 0.2 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.2 | 0.2 | GO:0007098 | centrosome cycle(GO:0007098) |
0.2 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 1.3 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.2 | 0.4 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.2 | 0.5 | GO:0007032 | endosome organization(GO:0007032) |
0.2 | 0.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.2 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 3.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.2 | 0.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 2.2 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 2.6 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.2 | 0.3 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.3 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.2 | 0.3 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.2 | 0.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.3 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
0.2 | 1.6 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.2 | 0.3 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.2 | 0.2 | GO:0071696 | ectodermal placode development(GO:0071696) |
0.2 | 0.3 | GO:0035865 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.2 | 2.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.2 | 0.9 | GO:0015893 | drug transport(GO:0015893) |
0.2 | 0.2 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.2 | 0.5 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.2 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.1 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.1 | 0.1 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 0.1 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.1 | GO:0044062 | regulation of excretion(GO:0044062) |
0.1 | 0.1 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) |
0.1 | 0.1 | GO:0032675 | regulation of interleukin-6 production(GO:0032675) |
0.1 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 0.1 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.1 | GO:0009132 | nucleoside diphosphate metabolic process(GO:0009132) |
0.1 | 0.3 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.1 | GO:0072224 | glomerular visceral epithelial cell development(GO:0072015) metanephric glomerulus development(GO:0072224) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.1 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.1 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.1 | 0.2 | GO:0030239 | myofibril assembly(GO:0030239) |
0.1 | 5.7 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
0.1 | 0.1 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 18.9 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.2 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.1 | 0.1 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.1 | 0.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.1 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.1 | GO:0097530 | granulocyte migration(GO:0097530) |
0.1 | 11.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 0.8 | GO:0051099 | positive regulation of binding(GO:0051099) |
0.1 | 0.1 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 1.1 | GO:0019935 | cAMP-mediated signaling(GO:0019933) cyclic-nucleotide-mediated signaling(GO:0019935) |
0.1 | 0.4 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.1 | 0.1 | GO:0042107 | cytokine metabolic process(GO:0042107) |
0.1 | 2.2 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.4 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 0.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.1 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.1 | 0.2 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.7 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.1 | 3.0 | GO:0006954 | inflammatory response(GO:0006954) |
0.1 | 0.1 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
0.1 | 0.2 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.1 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 0.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.1 | 0.2 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.1 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 2.9 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.1 | GO:0070192 | chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.0 | 0.0 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.3 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 36.4 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.0 | GO:0001562 | response to protozoan(GO:0001562) |
0.0 | 0.2 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.0 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.0 | 0.0 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.0 | 0.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.0 | 0.6 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.0 | 0.6 | GO:0006821 | chloride transport(GO:0006821) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.5 | 52.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
8.1 | 24.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
7.6 | 45.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
7.5 | 22.4 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
7.4 | 22.2 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
6.8 | 27.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
6.4 | 77.0 | GO:0042627 | chylomicron(GO:0042627) |
6.2 | 18.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
6.0 | 23.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
5.8 | 23.2 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
5.7 | 22.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
5.7 | 5.7 | GO:0032010 | phagolysosome(GO:0032010) |
5.4 | 32.5 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
5.4 | 16.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
5.4 | 16.2 | GO:0032127 | dense core granule membrane(GO:0032127) |
5.2 | 20.7 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
5.1 | 15.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
5.0 | 24.8 | GO:0031983 | vesicle lumen(GO:0031983) |
4.7 | 14.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
4.5 | 26.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
4.4 | 4.4 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
4.2 | 12.6 | GO:0097443 | sorting endosome(GO:0097443) |
4.1 | 41.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
4.1 | 16.4 | GO:0030478 | actin cap(GO:0030478) |
4.1 | 24.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
4.0 | 27.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
4.0 | 11.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.9 | 19.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
3.9 | 15.5 | GO:1990130 | Iml1 complex(GO:1990130) |
3.8 | 11.5 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
3.8 | 19.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
3.8 | 11.4 | GO:0097513 | myosin II filament(GO:0097513) |
3.7 | 11.2 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.7 | 29.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
3.7 | 11.0 | GO:0008091 | spectrin(GO:0008091) |
3.7 | 14.7 | GO:0042583 | chromaffin granule(GO:0042583) |
3.6 | 18.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
3.6 | 10.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
3.6 | 10.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
3.6 | 14.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
3.6 | 10.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
3.5 | 24.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
3.4 | 17.0 | GO:0030870 | Mre11 complex(GO:0030870) |
3.3 | 9.8 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
3.2 | 22.5 | GO:0043203 | axon hillock(GO:0043203) |
3.2 | 12.8 | GO:0071203 | WASH complex(GO:0071203) |
3.1 | 3.1 | GO:1990423 | RZZ complex(GO:1990423) |
3.1 | 6.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
3.1 | 21.6 | GO:0043219 | lateral loop(GO:0043219) |
3.1 | 12.3 | GO:0071439 | clathrin complex(GO:0071439) |
3.1 | 9.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
3.0 | 15.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
3.0 | 29.8 | GO:0046581 | intercellular canaliculus(GO:0046581) |
3.0 | 3.0 | GO:0033269 | internode region of axon(GO:0033269) |
3.0 | 68.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
2.9 | 11.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
2.9 | 11.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
2.9 | 2.9 | GO:0044455 | mitochondrial membrane part(GO:0044455) |
2.9 | 117.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
2.9 | 11.4 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.8 | 5.7 | GO:0031523 | Myb complex(GO:0031523) |
2.8 | 8.5 | GO:0097413 | Lewy body(GO:0097413) |
2.8 | 33.7 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
2.8 | 8.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
2.7 | 19.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.7 | 18.8 | GO:0045179 | apical cortex(GO:0045179) |
2.7 | 26.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.6 | 2.6 | GO:0046930 | pore complex(GO:0046930) |
2.6 | 7.7 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
2.6 | 10.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.5 | 27.8 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
2.5 | 35.1 | GO:0001891 | phagocytic cup(GO:0001891) |
2.5 | 12.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
2.5 | 2.5 | GO:0000125 | PCAF complex(GO:0000125) |
2.5 | 24.6 | GO:0002102 | podosome(GO:0002102) |
2.4 | 7.3 | GO:0098552 | side of membrane(GO:0098552) |
2.4 | 19.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
2.4 | 7.2 | GO:0031094 | platelet dense tubular network(GO:0031094) |
2.4 | 4.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
2.4 | 7.1 | GO:0000322 | storage vacuole(GO:0000322) |
2.4 | 54.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
2.3 | 7.0 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
2.3 | 27.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
2.3 | 11.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
2.3 | 4.6 | GO:0043218 | compact myelin(GO:0043218) |
2.3 | 6.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
2.3 | 4.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
2.3 | 2.3 | GO:0032432 | actin filament bundle(GO:0032432) |
2.3 | 142.8 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
2.3 | 11.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.3 | 13.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.3 | 9.0 | GO:0032133 | chromosome passenger complex(GO:0032133) |
2.3 | 38.3 | GO:0030904 | retromer complex(GO:0030904) |
2.2 | 9.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
2.2 | 6.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.2 | 6.7 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
2.2 | 2.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
2.2 | 6.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
2.2 | 6.6 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
2.2 | 4.4 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
2.2 | 129.7 | GO:0000118 | histone deacetylase complex(GO:0000118) |
2.2 | 48.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
2.2 | 6.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.2 | 6.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
2.2 | 6.5 | GO:0097342 | ripoptosome(GO:0097342) |
2.2 | 4.3 | GO:0016460 | myosin II complex(GO:0016460) |
2.1 | 6.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
2.1 | 4.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.1 | 64.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
2.1 | 12.8 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
2.1 | 17.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
2.1 | 10.7 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
2.1 | 113.0 | GO:0005811 | lipid particle(GO:0005811) |
2.1 | 6.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.1 | 2.1 | GO:0097422 | tubular endosome(GO:0097422) |
2.1 | 8.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
2.1 | 4.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.1 | 6.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
2.1 | 16.7 | GO:0005685 | U1 snRNP(GO:0005685) |
2.1 | 16.6 | GO:0042587 | glycogen granule(GO:0042587) |
2.1 | 18.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
2.1 | 8.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
2.0 | 4.1 | GO:0097255 | R2TP complex(GO:0097255) |
2.0 | 48.3 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
2.0 | 2.0 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
2.0 | 15.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
2.0 | 5.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
2.0 | 13.8 | GO:0042382 | paraspeckles(GO:0042382) |
2.0 | 11.8 | GO:0005796 | Golgi lumen(GO:0005796) |
2.0 | 7.8 | GO:0097440 | apical dendrite(GO:0097440) |
2.0 | 25.4 | GO:0016459 | myosin complex(GO:0016459) |
1.9 | 9.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.9 | 1.9 | GO:0033267 | axon part(GO:0033267) |
1.9 | 7.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.9 | 15.4 | GO:0005861 | troponin complex(GO:0005861) |
1.9 | 26.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.9 | 82.1 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
1.9 | 49.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
1.9 | 1.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
1.9 | 41.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
1.9 | 5.6 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.9 | 9.4 | GO:0005638 | lamin filament(GO:0005638) |
1.9 | 1.9 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.9 | 9.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
1.9 | 5.6 | GO:0035838 | growing cell tip(GO:0035838) |
1.8 | 20.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
1.8 | 79.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.8 | 7.4 | GO:0034709 | methylosome(GO:0034709) |
1.8 | 16.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.8 | 36.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.8 | 5.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.8 | 20.1 | GO:0005884 | actin filament(GO:0005884) |
1.8 | 3.6 | GO:0000805 | X chromosome(GO:0000805) |
1.8 | 10.9 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
1.8 | 21.7 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
1.8 | 16.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
1.8 | 14.2 | GO:0005869 | dynactin complex(GO:0005869) |
1.8 | 5.3 | GO:0036156 | inner dynein arm(GO:0036156) |
1.7 | 5.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.7 | 1.7 | GO:0000421 | autophagosome membrane(GO:0000421) |
1.7 | 8.6 | GO:0005579 | membrane attack complex(GO:0005579) |
1.7 | 12.1 | GO:0031931 | TORC1 complex(GO:0031931) |
1.7 | 10.3 | GO:0000796 | condensin complex(GO:0000796) |
1.7 | 8.6 | GO:0001651 | dense fibrillar component(GO:0001651) |
1.7 | 12.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.7 | 51.4 | GO:0012505 | endomembrane system(GO:0012505) |
1.7 | 5.1 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.7 | 8.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
1.7 | 85.4 | GO:0031526 | brush border membrane(GO:0031526) |
1.7 | 18.4 | GO:0031528 | microvillus membrane(GO:0031528) |
1.7 | 5.0 | GO:0070688 | MLL5-L complex(GO:0070688) |
1.7 | 21.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
1.7 | 18.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
1.7 | 3.3 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.7 | 11.6 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.7 | 6.6 | GO:0005642 | annulate lamellae(GO:0005642) |
1.7 | 33.2 | GO:0015030 | Cajal body(GO:0015030) |
1.6 | 14.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
1.6 | 11.5 | GO:0005688 | U6 snRNP(GO:0005688) |
1.6 | 4.9 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.6 | 13.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
1.6 | 13.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
1.6 | 21.2 | GO:0030120 | vesicle coat(GO:0030120) |
1.6 | 74.5 | GO:0005795 | Golgi stack(GO:0005795) |
1.6 | 4.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
1.6 | 148.5 | GO:0036064 | ciliary basal body(GO:0036064) |
1.6 | 126.2 | GO:0072562 | blood microparticle(GO:0072562) |
1.6 | 3.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.6 | 6.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
1.6 | 4.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
1.6 | 4.7 | GO:0000811 | GINS complex(GO:0000811) |
1.6 | 3.1 | GO:1990246 | uniplex complex(GO:1990246) |
1.6 | 9.4 | GO:0031143 | pseudopodium(GO:0031143) |
1.6 | 3.1 | GO:0031252 | cell leading edge(GO:0031252) |
1.5 | 12.3 | GO:0031209 | SCAR complex(GO:0031209) |
1.5 | 4.6 | GO:0031417 | NatC complex(GO:0031417) |
1.5 | 73.7 | GO:0042641 | actomyosin(GO:0042641) |
1.5 | 27.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
1.5 | 16.8 | GO:0032039 | integrator complex(GO:0032039) |
1.5 | 12.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.5 | 22.8 | GO:0045120 | pronucleus(GO:0045120) |
1.5 | 25.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
1.5 | 6.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.5 | 19.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
1.5 | 4.5 | GO:1990923 | PET complex(GO:1990923) |
1.5 | 25.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
1.5 | 4.5 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA telomerase RNP complex(GO:0090661) |
1.5 | 3.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
1.5 | 7.4 | GO:0000812 | Swr1 complex(GO:0000812) |
1.5 | 7.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.5 | 8.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
1.5 | 11.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
1.5 | 17.6 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
1.5 | 4.4 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
1.5 | 7.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.5 | 58.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.5 | 161.2 | GO:0000139 | Golgi membrane(GO:0000139) |
1.4 | 44.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.4 | 13.0 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
1.4 | 4.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.4 | 4.3 | GO:0097452 | GAIT complex(GO:0097452) |
1.4 | 18.7 | GO:0005682 | U5 snRNP(GO:0005682) |
1.4 | 15.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
1.4 | 10.0 | GO:0045171 | intercellular bridge(GO:0045171) |
1.4 | 1.4 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
1.4 | 5.7 | GO:0044666 | MLL3/4 complex(GO:0044666) |
1.4 | 45.2 | GO:0016592 | mediator complex(GO:0016592) |
1.4 | 5.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.4 | 7.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.4 | 19.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.4 | 11.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.4 | 11.1 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.4 | 5.5 | GO:0098536 | deuterosome(GO:0098536) |
1.4 | 8.3 | GO:0071010 | prespliceosome(GO:0071010) |
1.4 | 8.3 | GO:0071986 | Ragulator complex(GO:0071986) |
1.4 | 5.5 | GO:0045298 | tubulin complex(GO:0045298) |
1.4 | 330.4 | GO:0005924 | cell-substrate adherens junction(GO:0005924) |
1.4 | 2.7 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.4 | 5.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.4 | 1.4 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
1.3 | 63.4 | GO:0016363 | nuclear matrix(GO:0016363) |
1.3 | 4.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
1.3 | 9.4 | GO:0005776 | autophagosome(GO:0005776) |
1.3 | 8.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
1.3 | 1.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.3 | 19.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.3 | 9.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.3 | 7.9 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.3 | 21.0 | GO:0000145 | exocyst(GO:0000145) |
1.3 | 37.9 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.3 | 13.1 | GO:0032982 | myosin filament(GO:0032982) |
1.3 | 3.9 | GO:0044232 | organelle membrane contact site(GO:0044232) |
1.3 | 7.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
1.3 | 3.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.3 | 9.1 | GO:0031512 | motile primary cilium(GO:0031512) |
1.3 | 63.1 | GO:0005770 | late endosome(GO:0005770) |
1.3 | 14.1 | GO:0030667 | secretory granule membrane(GO:0030667) |
1.3 | 6.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.3 | 3.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
1.3 | 35.7 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.3 | 12.7 | GO:0000502 | proteasome complex(GO:0000502) |
1.3 | 17.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.3 | 1.3 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.3 | 1.3 | GO:0000814 | ESCRT II complex(GO:0000814) ESCRT complex(GO:0036452) |
1.3 | 6.3 | GO:0031932 | TORC2 complex(GO:0031932) |
1.3 | 1.3 | GO:0042827 | platelet dense granule(GO:0042827) |
1.3 | 116.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.2 | 5.0 | GO:0044194 | cytolytic granule(GO:0044194) |
1.2 | 2.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.2 | 18.7 | GO:0043196 | varicosity(GO:0043196) |
1.2 | 37.3 | GO:0005903 | brush border(GO:0005903) |
1.2 | 58.4 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.2 | 12.4 | GO:0035371 | microtubule plus-end(GO:0035371) |
1.2 | 3.7 | GO:0071953 | elastic fiber(GO:0071953) |
1.2 | 3.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.2 | 4.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.2 | 2.4 | GO:0000243 | commitment complex(GO:0000243) |
1.2 | 3.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.2 | 21.8 | GO:0005901 | caveola(GO:0005901) |
1.2 | 6.1 | GO:0097542 | ciliary tip(GO:0097542) |
1.2 | 9.6 | GO:0005865 | striated muscle thin filament(GO:0005865) |
1.2 | 2.4 | GO:0005775 | vacuolar lumen(GO:0005775) |
1.2 | 3.6 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
1.2 | 7.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.2 | 2.4 | GO:0044292 | dendrite terminus(GO:0044292) |
1.2 | 1.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
1.2 | 192.1 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
1.2 | 1.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
1.2 | 3.5 | GO:0071797 | LUBAC complex(GO:0071797) |
1.2 | 11.8 | GO:0035102 | PRC1 complex(GO:0035102) |
1.2 | 9.4 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.2 | 11.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
1.2 | 19.8 | GO:0005771 | multivesicular body(GO:0005771) |
1.2 | 8.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.2 | 22.1 | GO:0090544 | BAF-type complex(GO:0090544) |
1.2 | 9.3 | GO:0000346 | transcription export complex(GO:0000346) |
1.2 | 3.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.2 | 118.6 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.2 | 3.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.1 | 33.3 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
1.1 | 4.6 | GO:0005915 | zonula adherens(GO:0005915) |
1.1 | 4.6 | GO:0005640 | nuclear outer membrane(GO:0005640) |
1.1 | 11.4 | GO:0000242 | pericentriolar material(GO:0000242) |
1.1 | 3.4 | GO:0072687 | meiotic spindle(GO:0072687) |
1.1 | 4.5 | GO:0000938 | GARP complex(GO:0000938) |
1.1 | 6.7 | GO:0000974 | Prp19 complex(GO:0000974) |
1.1 | 2.2 | GO:0001650 | fibrillar center(GO:0001650) |
1.1 | 310.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.1 | 49.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
1.1 | 71.3 | GO:0000793 | condensed chromosome(GO:0000793) |
1.1 | 4.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
1.1 | 13.1 | GO:0044815 | DNA packaging complex(GO:0044815) |
1.1 | 3.3 | GO:0005955 | calcineurin complex(GO:0005955) |
1.1 | 3.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.1 | 8.5 | GO:0036157 | outer dynein arm(GO:0036157) |
1.1 | 4.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.1 | 1.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
1.1 | 18.0 | GO:0035861 | site of double-strand break(GO:0035861) |
1.1 | 29.6 | GO:0000428 | DNA-directed RNA polymerase complex(GO:0000428) nuclear DNA-directed RNA polymerase complex(GO:0055029) |
1.1 | 6.3 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
1.1 | 3.2 | GO:0097470 | ribbon synapse(GO:0097470) |
1.0 | 16.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
1.0 | 40.4 | GO:0005643 | nuclear pore(GO:0005643) |
1.0 | 2.1 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
1.0 | 9.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.0 | 2.1 | GO:0044327 | dendritic spine head(GO:0044327) |
1.0 | 6.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
1.0 | 4.1 | GO:0070545 | PeBoW complex(GO:0070545) |
1.0 | 1603.4 | GO:0070062 | extracellular exosome(GO:0070062) |
1.0 | 1.0 | GO:0034464 | BBSome(GO:0034464) |
1.0 | 5.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.0 | 6.9 | GO:0000801 | central element(GO:0000801) |
1.0 | 3.0 | GO:0070603 | SWI/SNF superfamily-type complex(GO:0070603) |
1.0 | 3.0 | GO:0072487 | MSL complex(GO:0072487) |
1.0 | 9.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.0 | 2.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.0 | 2.0 | GO:0071817 | MMXD complex(GO:0071817) |
1.0 | 73.1 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
1.0 | 1.9 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
1.0 | 1.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.0 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.0 | 6.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.0 | 1.0 | GO:0033270 | paranode region of axon(GO:0033270) |
1.0 | 1.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
1.0 | 2.9 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.9 | 0.9 | GO:0022624 | proteasome accessory complex(GO:0022624) |
0.9 | 5.6 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.9 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.9 | 37.4 | GO:0001726 | ruffle(GO:0001726) |
0.9 | 24.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.9 | 0.9 | GO:0061574 | ASAP complex(GO:0061574) |
0.9 | 0.9 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.9 | 20.7 | GO:0005938 | cell cortex(GO:0005938) |
0.9 | 24.0 | GO:0030496 | midbody(GO:0030496) |
0.9 | 7.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.9 | 5.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.9 | 1.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.9 | 30.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.9 | 6.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.9 | 53.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.9 | 47.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.9 | 3.4 | GO:0089701 | U2AF(GO:0089701) |
0.9 | 47.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.9 | 0.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.9 | 6.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.8 | 99.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 0.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.8 | 533.7 | GO:0005829 | cytosol(GO:0005829) |
0.8 | 16.7 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.8 | 4.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.8 | 25.9 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.8 | 0.8 | GO:0005912 | adherens junction(GO:0005912) |
0.8 | 2.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 1.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.8 | 0.8 | GO:0002139 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) |
0.8 | 2.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.8 | 3.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.8 | 4.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.8 | 5.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.8 | 7.9 | GO:0005657 | replication fork(GO:0005657) |
0.8 | 4.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.8 | 4.7 | GO:0016272 | prefoldin complex(GO:0016272) |
0.8 | 3.1 | GO:0035859 | Seh1-associated complex(GO:0035859) |
0.8 | 4.7 | GO:0099513 | supramolecular fiber(GO:0099512) polymeric cytoskeletal fiber(GO:0099513) |
0.8 | 0.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.8 | 712.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.8 | 19.9 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.8 | 2.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.8 | 15.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.7 | 3.7 | GO:0070652 | HAUS complex(GO:0070652) |
0.7 | 22.0 | GO:0031965 | nuclear membrane(GO:0031965) |
0.7 | 2.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.7 | 0.7 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.7 | 6.6 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.7 | 41.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.7 | 12.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.7 | 2.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.7 | 6.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.7 | 11.1 | GO:0010008 | endosome membrane(GO:0010008) |
0.7 | 0.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.7 | 8.2 | GO:0005844 | polysome(GO:0005844) |
0.7 | 1.4 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.7 | 3.4 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.7 | 1.3 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.7 | 2.0 | GO:0000922 | spindle pole(GO:0000922) |
0.6 | 134.3 | GO:0005730 | nucleolus(GO:0005730) |
0.6 | 3.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.6 | 1.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.6 | 3.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.6 | 0.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.6 | 0.6 | GO:0005914 | spot adherens junction(GO:0005914) |
0.6 | 1.2 | GO:0016234 | inclusion body(GO:0016234) |
0.6 | 2.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.6 | 0.6 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 75.2 | GO:0005813 | centrosome(GO:0005813) |
0.6 | 3.4 | GO:0071546 | pi-body(GO:0071546) |
0.6 | 2.8 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.6 | 1.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 292.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.5 | 1.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.5 | 7.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 308.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.5 | 4.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.5 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 31.7 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.5 | 1.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 7.1 | GO:0072372 | primary cilium(GO:0072372) |
0.5 | 6.5 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
0.5 | 2.9 | GO:0031519 | PcG protein complex(GO:0031519) |
0.5 | 0.5 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.5 | 1.0 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.5 | 66.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.5 | 0.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.5 | 0.5 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.5 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.5 | 2.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 13.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 7.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.4 | 0.9 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 0.9 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.4 | 1.3 | GO:0032426 | stereocilium tip(GO:0032426) |
0.4 | 6.8 | GO:0005922 | connexon complex(GO:0005922) |
0.4 | 0.4 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
0.4 | 0.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 2.5 | GO:0030057 | desmosome(GO:0030057) |
0.4 | 43.4 | GO:0005694 | chromosome(GO:0005694) |
0.4 | 1.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.4 | 14.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 0.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 13.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.4 | 2.7 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.4 | 3.0 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.4 | 0.7 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 191.9 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.3 | 2.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 31.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.3 | 35.5 | GO:0005768 | endosome(GO:0005768) |
0.3 | 1.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.3 | 1.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.3 | 0.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.3 | 4.5 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 4.8 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.3 | 12.5 | GO:0043234 | protein complex(GO:0043234) |
0.3 | 0.9 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.3 | 1.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.3 | 532.2 | GO:0005737 | cytoplasm(GO:0005737) |
0.3 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 0.5 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.2 | 0.2 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.1 | 0.6 | GO:0036126 | sperm flagellum(GO:0036126) |
0.1 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 57.0 | GO:0005576 | extracellular region(GO:0005576) |
0.1 | 332.7 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 17.3 | GO:0016020 | membrane(GO:0016020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.6 | 43.9 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
11.1 | 33.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
10.3 | 30.8 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
10.2 | 30.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
10.2 | 40.6 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
9.9 | 39.8 | GO:0015265 | urea channel activity(GO:0015265) |
9.9 | 39.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
9.1 | 27.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
8.8 | 26.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
7.5 | 22.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
7.3 | 51.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
7.2 | 28.7 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
6.8 | 20.3 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
6.5 | 19.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
6.5 | 19.4 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
6.4 | 25.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
6.4 | 19.3 | GO:0055100 | adiponectin binding(GO:0055100) |
6.3 | 18.9 | GO:0008142 | oxysterol binding(GO:0008142) |
6.2 | 18.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
6.1 | 18.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
6.1 | 12.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
6.0 | 12.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
6.0 | 18.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
5.9 | 41.6 | GO:0019966 | interleukin-1 binding(GO:0019966) |
5.7 | 17.0 | GO:0019770 | IgG receptor activity(GO:0019770) |
5.6 | 16.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
5.4 | 21.5 | GO:0009374 | biotin binding(GO:0009374) |
5.4 | 5.4 | GO:1901612 | cardiolipin binding(GO:1901612) |
5.3 | 15.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
5.2 | 20.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
5.1 | 5.1 | GO:0070538 | oleic acid binding(GO:0070538) |
5.0 | 15.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
4.9 | 19.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
4.9 | 14.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
4.9 | 14.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
4.8 | 47.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
4.8 | 33.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
4.7 | 32.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
4.6 | 13.8 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
4.6 | 13.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
4.6 | 18.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
4.5 | 36.3 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
4.5 | 18.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
4.5 | 31.3 | GO:0046790 | virion binding(GO:0046790) |
4.4 | 13.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
4.4 | 17.7 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
4.4 | 4.4 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
4.4 | 13.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
4.4 | 13.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
4.3 | 12.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
4.3 | 17.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
4.3 | 46.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
4.2 | 21.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
4.2 | 12.6 | GO:2001069 | glycogen binding(GO:2001069) |
4.1 | 12.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
4.1 | 12.3 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
4.1 | 16.4 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
4.1 | 20.4 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
4.1 | 16.3 | GO:0035276 | ethanol binding(GO:0035276) |
4.1 | 73.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
4.1 | 16.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
4.1 | 16.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
4.1 | 12.2 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
4.1 | 8.1 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
4.0 | 12.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
4.0 | 16.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
4.0 | 32.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
4.0 | 15.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
4.0 | 47.6 | GO:0017166 | vinculin binding(GO:0017166) |
4.0 | 11.9 | GO:0050692 | DBD domain binding(GO:0050692) |
3.9 | 11.7 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
3.9 | 15.6 | GO:0045340 | mercury ion binding(GO:0045340) |
3.9 | 23.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
3.9 | 11.6 | GO:0004064 | arylesterase activity(GO:0004064) |
3.9 | 11.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
3.9 | 138.7 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
3.8 | 11.5 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
3.8 | 19.2 | GO:0051525 | NFAT protein binding(GO:0051525) |
3.8 | 15.3 | GO:0043515 | kinetochore binding(GO:0043515) |
3.8 | 15.2 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
3.8 | 15.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
3.8 | 11.3 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
3.7 | 7.5 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
3.7 | 3.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
3.7 | 14.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
3.7 | 29.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
3.7 | 25.7 | GO:0018640 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
3.7 | 43.8 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
3.6 | 25.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
3.6 | 7.2 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
3.6 | 10.7 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
3.6 | 17.9 | GO:0008199 | ferric iron binding(GO:0008199) |
3.6 | 14.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
3.6 | 7.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
3.6 | 10.7 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
3.4 | 17.2 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
3.4 | 27.5 | GO:0008430 | selenium binding(GO:0008430) |
3.4 | 6.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
3.4 | 10.3 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
3.4 | 30.5 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
3.4 | 13.5 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
3.4 | 16.8 | GO:0002054 | nucleobase binding(GO:0002054) |
3.4 | 13.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
3.3 | 10.0 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
3.3 | 13.3 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.3 | 23.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
3.3 | 6.6 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
3.3 | 26.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
3.3 | 9.8 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
3.3 | 3.3 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
3.3 | 9.8 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
3.3 | 9.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
3.2 | 22.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
3.2 | 3.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
3.2 | 25.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
3.2 | 19.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
3.2 | 25.4 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
3.2 | 25.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
3.2 | 18.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
3.2 | 18.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
3.1 | 12.5 | GO:0052794 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
3.1 | 27.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
3.1 | 52.3 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
3.1 | 15.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
3.1 | 6.1 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
3.1 | 12.3 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
3.1 | 24.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
3.0 | 3.0 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
3.0 | 9.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
3.0 | 6.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
3.0 | 45.1 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
3.0 | 24.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
3.0 | 24.0 | GO:0060229 | lipase activator activity(GO:0060229) |
3.0 | 8.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
3.0 | 17.8 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
3.0 | 17.8 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
3.0 | 14.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.9 | 17.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
2.9 | 17.6 | GO:0050733 | RS domain binding(GO:0050733) |
2.9 | 2.9 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
2.9 | 2.9 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.9 | 14.5 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
2.9 | 8.7 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
2.9 | 14.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
2.9 | 17.4 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.9 | 17.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
2.9 | 14.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.9 | 23.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
2.9 | 43.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
2.9 | 2.9 | GO:1990188 | euchromatin binding(GO:1990188) |
2.9 | 8.6 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
2.9 | 25.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
2.8 | 28.5 | GO:0043274 | phospholipase binding(GO:0043274) |
2.8 | 2.8 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
2.8 | 11.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.8 | 17.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
2.8 | 5.6 | GO:0016748 | succinyltransferase activity(GO:0016748) |
2.8 | 13.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
2.8 | 22.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
2.7 | 5.5 | GO:0050693 | LBD domain binding(GO:0050693) |
2.7 | 2.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
2.7 | 13.7 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
2.7 | 19.1 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
2.7 | 8.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
2.7 | 16.3 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
2.7 | 10.8 | GO:0015232 | heme transporter activity(GO:0015232) |
2.7 | 10.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.7 | 5.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.7 | 24.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
2.7 | 5.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.7 | 13.5 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
2.7 | 24.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
2.7 | 8.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
2.7 | 8.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
2.6 | 52.9 | GO:0001221 | transcription cofactor binding(GO:0001221) |
2.6 | 7.9 | GO:0045118 | L-histidine transmembrane transporter activity(GO:0005290) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
2.6 | 94.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
2.6 | 2.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.6 | 7.8 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
2.6 | 7.8 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
2.6 | 2.6 | GO:0089720 | caspase binding(GO:0089720) |
2.6 | 15.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
2.6 | 7.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
2.6 | 13.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
2.6 | 2.6 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
2.6 | 10.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.6 | 38.7 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
2.6 | 10.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.6 | 2.6 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
2.6 | 7.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
2.6 | 7.7 | GO:0031078 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
2.6 | 30.7 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
2.5 | 5.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
2.5 | 7.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.5 | 7.6 | GO:0030172 | troponin C binding(GO:0030172) |
2.5 | 10.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
2.5 | 7.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
2.5 | 7.5 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
2.5 | 12.4 | GO:0016936 | galactoside binding(GO:0016936) |
2.5 | 32.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
2.5 | 4.9 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.5 | 9.9 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
2.5 | 7.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
2.4 | 9.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
2.4 | 12.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
2.4 | 12.2 | GO:1990239 | steroid hormone binding(GO:1990239) |
2.4 | 2.4 | GO:0031432 | titin binding(GO:0031432) |
2.4 | 12.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
2.4 | 7.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
2.4 | 12.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
2.4 | 9.6 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
2.4 | 2.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
2.3 | 9.4 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.3 | 4.7 | GO:1990715 | mRNA CDS binding(GO:1990715) |
2.3 | 4.7 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.3 | 16.3 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
2.3 | 20.9 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
2.3 | 11.6 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
2.3 | 7.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
2.3 | 4.6 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
2.3 | 9.2 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
2.3 | 4.6 | GO:0030984 | kininogen binding(GO:0030984) |
2.3 | 6.9 | GO:0070061 | fructose binding(GO:0070061) |
2.3 | 29.6 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
2.3 | 36.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
2.3 | 20.4 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
2.3 | 22.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
2.3 | 11.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
2.3 | 2.3 | GO:0032190 | acrosin binding(GO:0032190) |
2.3 | 24.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
2.2 | 31.4 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
2.2 | 6.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.2 | 13.4 | GO:0043426 | MRF binding(GO:0043426) |
2.2 | 73.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
2.2 | 20.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
2.2 | 17.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
2.2 | 26.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
2.2 | 64.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
2.2 | 4.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
2.2 | 4.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.2 | 11.0 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
2.2 | 21.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.2 | 30.7 | GO:0008483 | transaminase activity(GO:0008483) |
2.2 | 6.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
2.2 | 4.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
2.2 | 4.3 | GO:0070402 | NADPH binding(GO:0070402) |
2.2 | 10.8 | GO:0070728 | leucine binding(GO:0070728) |
2.2 | 10.8 | GO:0017040 | ceramidase activity(GO:0017040) |
2.1 | 47.0 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
2.1 | 2.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
2.1 | 17.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
2.1 | 14.9 | GO:0071949 | FAD binding(GO:0071949) |
2.1 | 8.5 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
2.1 | 50.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
2.1 | 2.1 | GO:0097617 | annealing activity(GO:0097617) |
2.1 | 21.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.1 | 29.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
2.1 | 60.6 | GO:0004177 | aminopeptidase activity(GO:0004177) |
2.1 | 6.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
2.1 | 25.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
2.1 | 8.3 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
2.1 | 20.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
2.1 | 12.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
2.1 | 22.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
2.1 | 6.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.0 | 30.7 | GO:0005521 | lamin binding(GO:0005521) |
2.0 | 2.0 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
2.0 | 10.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
2.0 | 12.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
2.0 | 6.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.0 | 12.1 | GO:0018503 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
2.0 | 8.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.0 | 18.1 | GO:0050308 | sugar-phosphatase activity(GO:0050308) |
2.0 | 233.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
2.0 | 6.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
2.0 | 39.7 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.0 | 5.9 | GO:0004104 | cholinesterase activity(GO:0004104) |
2.0 | 2.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
2.0 | 56.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
2.0 | 15.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.0 | 25.4 | GO:0005123 | death receptor binding(GO:0005123) |
2.0 | 13.7 | GO:0001846 | opsonin binding(GO:0001846) |
1.9 | 5.8 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.9 | 7.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.9 | 19.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.9 | 5.8 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
1.9 | 9.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
1.9 | 9.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.9 | 5.8 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
1.9 | 5.8 | GO:0043199 | sulfate binding(GO:0043199) |
1.9 | 9.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.9 | 7.6 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.9 | 36.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
1.9 | 34.0 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.9 | 5.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
1.9 | 1.9 | GO:0030284 | estrogen receptor activity(GO:0030284) |
1.9 | 7.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.9 | 3.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.9 | 5.6 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.9 | 7.5 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.9 | 7.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.9 | 1.9 | GO:0035173 | histone kinase activity(GO:0035173) |
1.9 | 5.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.9 | 11.1 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
1.9 | 27.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
1.8 | 5.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.8 | 24.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
1.8 | 12.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
1.8 | 1.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
1.8 | 16.4 | GO:0010181 | FMN binding(GO:0010181) |
1.8 | 10.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
1.8 | 27.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
1.8 | 1.8 | GO:0034046 | poly(G) binding(GO:0034046) |
1.8 | 5.4 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) amidine-lyase activity(GO:0016842) |
1.8 | 9.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.8 | 3.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.8 | 3.6 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
1.8 | 23.5 | GO:0008143 | poly(A) binding(GO:0008143) |
1.8 | 9.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
1.8 | 1.8 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
1.8 | 1.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.8 | 19.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.8 | 3.6 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
1.8 | 5.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.8 | 3.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
1.8 | 3.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.8 | 7.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
1.8 | 137.4 | GO:0005178 | integrin binding(GO:0005178) |
1.8 | 28.1 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.8 | 3.5 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.8 | 12.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.7 | 10.5 | GO:0001848 | complement binding(GO:0001848) |
1.7 | 22.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.7 | 5.2 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.7 | 6.9 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.7 | 10.3 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.7 | 20.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
1.7 | 8.6 | GO:0004556 | alpha-amylase activity(GO:0004556) |
1.7 | 12.0 | GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
1.7 | 3.4 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
1.7 | 3.4 | GO:0004359 | glutaminase activity(GO:0004359) |
1.7 | 5.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
1.7 | 6.9 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.7 | 29.2 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
1.7 | 3.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.7 | 1.7 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
1.7 | 6.8 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
1.7 | 5.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
1.7 | 5.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.7 | 5.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.7 | 3.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
1.7 | 3.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.7 | 5.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.7 | 41.6 | GO:0015485 | cholesterol binding(GO:0015485) |
1.7 | 28.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.7 | 179.0 | GO:0005506 | iron ion binding(GO:0005506) |
1.7 | 24.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.6 | 18.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.6 | 1.6 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.6 | 26.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
1.6 | 11.4 | GO:0031996 | thioesterase binding(GO:0031996) |
1.6 | 154.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.6 | 3.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.6 | 3.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
1.6 | 4.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.6 | 98.3 | GO:0051087 | chaperone binding(GO:0051087) |
1.6 | 14.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.6 | 4.8 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.6 | 57.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
1.6 | 4.8 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.6 | 73.6 | GO:0003684 | damaged DNA binding(GO:0003684) |
1.6 | 8.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
1.6 | 8.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.6 | 9.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.6 | 20.6 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
1.6 | 4.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.6 | 20.5 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
1.6 | 4.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
1.6 | 11.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
1.6 | 4.7 | GO:0071253 | connexin binding(GO:0071253) |
1.6 | 11.0 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
1.6 | 14.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.6 | 4.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.6 | 4.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
1.6 | 20.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.6 | 6.2 | GO:0102345 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
1.6 | 24.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.5 | 18.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.5 | 7.7 | GO:0070403 | NAD+ binding(GO:0070403) |
1.5 | 12.3 | GO:0018450 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
1.5 | 7.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.5 | 6.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.5 | 44.1 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
1.5 | 6.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
1.5 | 3.0 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
1.5 | 1.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.5 | 13.6 | GO:0004568 | chitinase activity(GO:0004568) |
1.5 | 10.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.5 | 7.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.5 | 1.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.5 | 4.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.5 | 4.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
1.5 | 5.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.5 | 7.4 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
1.5 | 14.8 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.5 | 3.0 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.5 | 2.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.5 | 14.7 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
1.5 | 52.8 | GO:0005507 | copper ion binding(GO:0005507) |
1.5 | 13.2 | GO:0019841 | retinol binding(GO:0019841) |
1.5 | 8.8 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
1.5 | 23.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
1.5 | 4.4 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.5 | 2.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.5 | 7.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
1.5 | 2.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
1.4 | 1.4 | GO:0019808 | polyamine binding(GO:0019808) |
1.4 | 8.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
1.4 | 1.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.4 | 7.2 | GO:0005499 | vitamin D binding(GO:0005499) |
1.4 | 4.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
1.4 | 7.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
1.4 | 4.3 | GO:0005534 | galactose binding(GO:0005534) |
1.4 | 12.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
1.4 | 5.7 | GO:0005113 | patched binding(GO:0005113) |
1.4 | 8.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.4 | 18.5 | GO:0043236 | laminin binding(GO:0043236) |
1.4 | 11.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.4 | 5.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
1.4 | 7.0 | GO:0043531 | ADP binding(GO:0043531) |
1.4 | 30.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
1.4 | 5.6 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
1.4 | 2.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.4 | 8.3 | GO:0008494 | translation activator activity(GO:0008494) |
1.4 | 5.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.4 | 6.9 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
1.4 | 9.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.4 | 13.5 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
1.3 | 8.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.3 | 5.4 | GO:0031419 | cobalamin binding(GO:0031419) |
1.3 | 2.7 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
1.3 | 9.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
1.3 | 10.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
1.3 | 29.4 | GO:0030145 | manganese ion binding(GO:0030145) |
1.3 | 9.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.3 | 6.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.3 | 18.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
1.3 | 224.8 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
1.3 | 5.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.3 | 3.9 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
1.3 | 1.3 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
1.3 | 13.1 | GO:0001618 | virus receptor activity(GO:0001618) |
1.3 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
1.3 | 3.9 | GO:0061665 | SUMO ligase activity(GO:0061665) |
1.3 | 3.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.3 | 3.9 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 2.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.3 | 13.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.3 | 6.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.3 | 1.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.3 | 5.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.3 | 1.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.3 | 2.6 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
1.3 | 8.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.3 | 2.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.3 | 3.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.3 | 3.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.3 | 3.8 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
1.3 | 5.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.2 | 10.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.2 | 6.2 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.2 | 3.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
1.2 | 3.7 | GO:0036033 | mediator complex binding(GO:0036033) |
1.2 | 4.9 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.2 | 1.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.2 | 4.9 | GO:0035671 | enone reductase activity(GO:0035671) |
1.2 | 6.1 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
1.2 | 2.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.2 | 2.4 | GO:0019961 | interferon binding(GO:0019961) |
1.2 | 150.8 | GO:0051020 | GTPase binding(GO:0051020) |
1.2 | 4.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
1.2 | 2.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.2 | 1.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.2 | 4.8 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.2 | 12.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.2 | 3.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.2 | 5.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
1.2 | 5.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
1.2 | 3.5 | GO:1990405 | protein antigen binding(GO:1990405) |
1.2 | 4.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.2 | 1.2 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.2 | 12.8 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 23.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.2 | 83.6 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
1.2 | 4.6 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
1.2 | 3.5 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
1.2 | 8.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.2 | 25.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
1.1 | 2.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
1.1 | 1.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
1.1 | 12.6 | GO:0000049 | tRNA binding(GO:0000049) |
1.1 | 3.4 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
1.1 | 9.1 | GO:0046977 | TAP binding(GO:0046977) |
1.1 | 1.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
1.1 | 27.2 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.1 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
1.1 | 58.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
1.1 | 41.8 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
1.1 | 3.4 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
1.1 | 3.4 | GO:0030515 | snoRNA binding(GO:0030515) |
1.1 | 29.3 | GO:0050699 | WW domain binding(GO:0050699) |
1.1 | 1.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.1 | 11.2 | GO:0045502 | dynein binding(GO:0045502) |
1.1 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.1 | 25.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.1 | 1.1 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
1.1 | 3.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.1 | 12.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
1.1 | 21.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.1 | 10.0 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.1 | 7.7 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.1 | 3.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.1 | 9.9 | GO:0048038 | quinone binding(GO:0048038) |
1.1 | 2.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
1.1 | 3.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
1.1 | 2.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.1 | 9.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.1 | 25.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.1 | 29.0 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
1.1 | 2.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
1.1 | 2.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
1.1 | 9.6 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.1 | 26.7 | GO:0051287 | NAD binding(GO:0051287) |
1.1 | 3.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.1 | 4.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.1 | 8.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.0 | 1.0 | GO:0060590 | ATPase regulator activity(GO:0060590) |
1.0 | 3.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.0 | 4.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.0 | 5.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.0 | 7.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.0 | 2.0 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
1.0 | 2.0 | GO:0031433 | telethonin binding(GO:0031433) |
1.0 | 30.6 | GO:0016420 | S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
1.0 | 3.0 | GO:0042731 | PH domain binding(GO:0042731) |
1.0 | 11.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
1.0 | 19.2 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
1.0 | 4.0 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 1.0 | GO:0008061 | chitin binding(GO:0008061) |
1.0 | 22.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
1.0 | 11.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
1.0 | 4.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.0 | 4.0 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.0 | 28.6 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
1.0 | 3.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.0 | 2.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
1.0 | 47.2 | GO:0008565 | protein transporter activity(GO:0008565) |
1.0 | 2.0 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
1.0 | 2.0 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
1.0 | 27.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
1.0 | 2.9 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.0 | 21.4 | GO:0042393 | histone binding(GO:0042393) |
1.0 | 19.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
1.0 | 3.9 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.0 | 2.9 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.0 | 1.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.0 | 1.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.0 | 1.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.0 | 2.9 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.0 | 1.9 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.0 | 6.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.0 | 1.9 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
1.0 | 7.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.9 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.9 | 9.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.9 | 12.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.9 | 0.9 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.9 | 2.8 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.9 | 2.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.9 | 13.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.9 | 0.9 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.9 | 0.9 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.9 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.9 | 2.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 10.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.9 | 2.8 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.9 | 3.7 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.9 | 0.9 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.9 | 6.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.9 | 3.6 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.9 | 3.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.9 | 1.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.9 | 17.1 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.9 | 7.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.9 | 2.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.9 | 1.8 | GO:0034452 | dynactin binding(GO:0034452) |
0.9 | 5.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.9 | 4.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.9 | 22.0 | GO:0019843 | rRNA binding(GO:0019843) |
0.9 | 28.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.9 | 1.7 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.9 | 2.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.9 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.9 | 2.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.9 | 0.9 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.9 | 5.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.9 | 1.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.9 | 3.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.9 | 1.7 | GO:0019862 | IgA binding(GO:0019862) |
0.9 | 4.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.9 | 0.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.9 | 28.3 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.9 | 0.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.9 | 1.7 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.9 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.9 | 6.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.9 | 101.4 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.8 | 22.0 | GO:0043621 | protein self-association(GO:0043621) |
0.8 | 1.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.8 | 1.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 2.5 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.8 | 2.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.8 | 1.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 4.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.8 | 4.2 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.8 | 3.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.8 | 10.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.8 | 16.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.8 | 6.6 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.8 | 19.9 | GO:0019706 | palmitoyltransferase activity(GO:0016409) protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.8 | 3.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.8 | 5.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.8 | 5.7 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.8 | 2.4 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.8 | 13.0 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.8 | 6.5 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.8 | 3.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.8 | 1.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.8 | 3.2 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.8 | 67.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.8 | 0.8 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.8 | 9.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.8 | 63.3 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.8 | 8.6 | GO:0030506 | ankyrin binding(GO:0030506) |
0.8 | 7.0 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.8 | 2.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.8 | 1.5 | GO:0043559 | insulin binding(GO:0043559) |
0.8 | 5.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.8 | 1.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.8 | 2.3 | GO:0019002 | GMP binding(GO:0019002) |
0.8 | 1.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.8 | 45.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.8 | 1.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.8 | 1.5 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.8 | 2.3 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.8 | 6.8 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 1.5 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.7 | 3.0 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.7 | 75.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.7 | 2.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.7 | 4.5 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.7 | 3.0 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.7 | 8.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 5.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.7 | 0.7 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.7 | 0.7 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.7 | 2.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.7 | 11.5 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.7 | 5.8 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.7 | 1.4 | GO:0031690 | adrenergic receptor binding(GO:0031690) |
0.7 | 3.6 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.7 | 9.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.7 | 10.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.7 | 5.7 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.7 | 2.1 | GO:0005536 | glucose binding(GO:0005536) |
0.7 | 2.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.7 | 4.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.7 | 4.3 | GO:0030955 | potassium ion binding(GO:0030955) |
0.7 | 28.3 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.7 | 2.8 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) peptidoglycan binding(GO:0042834) |
0.7 | 0.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.7 | 28.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.7 | 2.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.7 | 2.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.7 | 20.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.7 | 0.7 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.7 | 1.4 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.7 | 3.5 | GO:0004519 | endonuclease activity(GO:0004519) |
0.7 | 22.2 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.7 | 2.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.7 | 2.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.7 | 20.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.7 | 1.4 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.7 | 5.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.7 | 0.7 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.7 | 8.9 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.7 | 1.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.7 | 2.0 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.7 | 29.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.7 | 0.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.7 | 0.7 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.7 | 13.3 | GO:0008009 | chemokine activity(GO:0008009) |
0.7 | 4.0 | GO:0080011 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.7 | 0.7 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.7 | 3.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.7 | 2.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.7 | 1.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.7 | 3.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.7 | 1.3 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.7 | 2.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.7 | 15.7 | GO:0019209 | kinase activator activity(GO:0019209) |
0.6 | 3.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.6 | 19.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.6 | 21.2 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
0.6 | 0.6 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.6 | 1.3 | GO:0038100 | nodal binding(GO:0038100) |
0.6 | 3.2 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.6 | 0.6 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.6 | 50.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.6 | 9.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.6 | 5.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.6 | 3.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.6 | 10.1 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.6 | 2.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.6 | 1.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.6 | 26.1 | GO:0019003 | GDP binding(GO:0019003) |
0.6 | 100.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.6 | 10.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.6 | 5.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.6 | 3.1 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.6 | 2.5 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 30.4 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.6 | 25.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.6 | 1.2 | GO:0090484 | drug transporter activity(GO:0090484) |
0.6 | 14.2 | GO:0005518 | collagen binding(GO:0005518) |
0.6 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.6 | 2.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.6 | 18.3 | GO:0005496 | steroid binding(GO:0005496) |
0.6 | 7.3 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.6 | 2.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.6 | 2.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.6 | 7.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.6 | 3.0 | GO:0044548 | S100 protein binding(GO:0044548) |
0.6 | 119.0 | GO:0005525 | GTP binding(GO:0005525) |
0.6 | 16.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.6 | 1.8 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.6 | 6.5 | GO:0042805 | actinin binding(GO:0042805) |
0.6 | 1.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.6 | 2.9 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.6 | 12.4 | GO:0005109 | frizzled binding(GO:0005109) |
0.6 | 71.5 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.6 | 9.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.6 | 1.7 | GO:0002046 | opsin binding(GO:0002046) |
0.6 | 5.7 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.6 | 38.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.6 | 2.3 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.6 | 353.9 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.6 | 2.2 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.6 | 0.6 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.6 | 6.1 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 43.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.5 | 1.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 16.8 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.5 | 10.8 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.5 | 1.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 16.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.5 | 4.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.5 | 4.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.5 | 3.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.5 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 2.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 112.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.5 | 8.7 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.5 | 3.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 5.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.5 | 1.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 63.7 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.5 | 1.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.5 | 1.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.5 | 0.5 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.5 | 1.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.5 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 1.0 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.5 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.5 | 3.8 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.5 | 20.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.5 | 7.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.5 | 0.9 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.5 | 5.4 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.5 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.4 | 0.4 | GO:0032404 | mismatch repair complex binding(GO:0032404) MutSalpha complex binding(GO:0032407) |
0.4 | 0.4 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 0.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 9.2 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.4 | 2.6 | GO:0019955 | cytokine binding(GO:0019955) |
0.4 | 20.9 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.4 | 4.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.4 | 0.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 0.8 | GO:0044213 | intronic transcription regulatory region DNA binding(GO:0044213) |
0.4 | 9.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.4 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.4 | 0.8 | GO:0033170 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.4 | 1.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.4 | 1.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 3.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 2.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.4 | 40.3 | GO:0003682 | chromatin binding(GO:0003682) |
0.4 | 30.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 1.5 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.4 | 1.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.4 | 37.1 | GO:0008134 | transcription factor binding(GO:0008134) |
0.4 | 1.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.4 | 0.7 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 1.1 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.3 | 8.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 16.5 | GO:0019902 | phosphatase binding(GO:0019902) |
0.3 | 11.0 | GO:0016887 | ATPase activity(GO:0016887) |
0.3 | 1.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 0.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.3 | 0.7 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.3 | 31.4 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.3 | 0.9 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.3 | 1.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.3 | 0.3 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.3 | 1.5 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.3 | 9.9 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.3 | 0.9 | GO:0000182 | rDNA binding(GO:0000182) |
0.3 | 0.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 2.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 32.3 | GO:0005125 | cytokine activity(GO:0005125) |
0.3 | 0.3 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.3 | 1.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 2.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.3 | 1.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 3.1 | GO:0070888 | E-box binding(GO:0070888) |
0.3 | 31.1 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.3 | 0.8 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
0.3 | 3.1 | GO:0016209 | antioxidant activity(GO:0016209) |
0.3 | 0.3 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.3 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.3 | 0.5 | GO:0005048 | signal sequence binding(GO:0005048) |
0.3 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.3 | 0.8 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.3 | 7.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 0.5 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 10.0 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 13.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.2 | 2.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 5.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.2 | 1.2 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 5.1 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.2 | 1.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.2 | 1.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.2 | 0.7 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 2.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.5 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.2 | 2.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 24.5 | GO:0003723 | RNA binding(GO:0003723) |
0.2 | 31.3 | GO:0046982 | protein heterodimerization activity(GO:0046982) |
0.2 | 0.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.2 | 15.8 | GO:0003774 | motor activity(GO:0003774) |
0.2 | 0.8 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 0.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 0.8 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.2 | 0.7 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.2 | 14.8 | GO:0005550 | pheromone binding(GO:0005550) |
0.2 | 0.5 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.2 | 0.2 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.2 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.1 | 0.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 1.6 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.1 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.1 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 0.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.2 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 1.2 | GO:0003823 | antigen binding(GO:0003823) |
0.1 | 0.2 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
0.1 | 0.2 | GO:0051184 | cofactor transporter activity(GO:0051184) |
0.1 | 1.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.1 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.1 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.1 | 1.9 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 0.0 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.0 | 51.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.0 | 0.7 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 7.4 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.0 | 0.0 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0042562 | hormone binding(GO:0042562) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 11.0 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
4.4 | 193.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
4.1 | 45.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
3.8 | 22.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
3.5 | 115.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
3.5 | 108.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
3.4 | 27.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
3.1 | 102.8 | PID ARF6 PATHWAY | Arf6 signaling events |
3.1 | 30.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
2.8 | 45.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
2.8 | 67.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
2.8 | 53.3 | PID IGF1 PATHWAY | IGF1 pathway |
2.7 | 2.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.6 | 38.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
2.6 | 56.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
2.5 | 15.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
2.5 | 77.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.5 | 44.7 | PID AURORA A PATHWAY | Aurora A signaling |
2.4 | 89.3 | PID AURORA B PATHWAY | Aurora B signaling |
2.3 | 112.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
2.3 | 50.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
2.3 | 13.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
2.2 | 4.5 | ST STAT3 PATHWAY | STAT3 Pathway |
2.2 | 6.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
2.2 | 6.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
2.2 | 50.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
2.2 | 49.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
2.1 | 25.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.1 | 82.5 | PID P53 REGULATION PATHWAY | p53 pathway |
2.1 | 33.0 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
2.0 | 40.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
2.0 | 31.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.9 | 26.3 | PID IFNG PATHWAY | IFN-gamma pathway |
1.9 | 28.2 | PID MYC PATHWAY | C-MYC pathway |
1.9 | 13.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.9 | 29.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
1.9 | 11.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
1.8 | 18.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.8 | 18.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.8 | 47.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
1.8 | 10.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.8 | 57.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
1.8 | 41.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.8 | 44.5 | PID RHOA PATHWAY | RhoA signaling pathway |
1.8 | 7.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.8 | 36.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
1.7 | 44.9 | PID BCR 5PATHWAY | BCR signaling pathway |
1.7 | 63.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.7 | 25.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.7 | 22.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.7 | 13.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
1.7 | 15.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.7 | 16.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.6 | 4.9 | PID CD40 PATHWAY | CD40/CD40L signaling |
1.6 | 1.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.6 | 43.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
1.6 | 24.1 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.6 | 15.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.6 | 42.3 | PID LKB1 PATHWAY | LKB1 signaling events |
1.6 | 62.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
1.6 | 28.0 | PID BARD1 PATHWAY | BARD1 signaling events |
1.6 | 6.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
1.5 | 4.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
1.5 | 25.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.5 | 38.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.5 | 2.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.4 | 27.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
1.4 | 14.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.4 | 7.0 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.4 | 6.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.4 | 81.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
1.3 | 9.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.3 | 21.3 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
1.3 | 3.9 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.3 | 22.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.3 | 21.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.3 | 7.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.3 | 7.7 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.3 | 2.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.3 | 33.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
1.2 | 29.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.2 | 37.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
1.2 | 45.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.2 | 36.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.2 | 9.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
1.2 | 2.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.2 | 10.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
1.2 | 1.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.1 | 11.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.1 | 2.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.0 | 22.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.0 | 25.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
1.0 | 10.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.0 | 16.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.9 | 15.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.9 | 21.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.9 | 8.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.9 | 17.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.9 | 13.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 5.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.8 | 1.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.8 | 11.0 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.8 | 6.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.8 | 4.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.8 | 23.5 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.8 | 32.6 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.8 | 7.9 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.8 | 4.7 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.8 | 13.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.8 | 1.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.8 | 10.0 | PID ARF 3PATHWAY | Arf1 pathway |
0.8 | 16.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 8.9 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.7 | 4.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 0.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.7 | 4.9 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.7 | 8.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.7 | 126.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.7 | 11.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.7 | 3.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.6 | 2.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.6 | 3.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.6 | 3.1 | PID FOXO PATHWAY | FoxO family signaling |
0.6 | 1.8 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 12.4 | PID E2F PATHWAY | E2F transcription factor network |
0.6 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 2.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 6.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.5 | 0.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.5 | 11.0 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.5 | 3.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.5 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 3.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.5 | 5.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.5 | 3.9 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.5 | 6.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 1.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.4 | 57.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 2.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.4 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 13.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.4 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.4 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 1.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.4 | 1.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 3.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 7.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.3 | 0.6 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 3.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 0.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 0.9 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.3 | 1.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 5.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 2.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 0.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 1.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 1.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.2 | 30.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 1.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 2.8 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 1.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.8 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.9 | 6.9 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
6.0 | 60.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
5.3 | 42.6 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
5.3 | 84.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
4.4 | 75.6 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
4.1 | 37.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
4.1 | 12.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
4.1 | 4.1 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
4.0 | 98.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
3.9 | 3.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
3.8 | 87.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
3.8 | 101.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
3.7 | 67.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
3.7 | 11.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
3.6 | 50.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
3.6 | 50.1 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.5 | 35.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
3.4 | 44.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
3.4 | 40.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.3 | 3.3 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
3.3 | 26.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
3.3 | 16.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
3.3 | 55.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
3.2 | 41.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
3.1 | 3.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
3.0 | 90.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
2.9 | 37.8 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
2.9 | 2.9 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
2.9 | 17.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.9 | 31.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
2.8 | 2.8 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
2.8 | 14.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.8 | 31.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
2.8 | 72.3 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.7 | 2.7 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
2.7 | 62.3 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
2.7 | 67.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
2.7 | 40.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
2.7 | 32.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
2.7 | 29.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
2.6 | 7.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.6 | 33.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
2.6 | 5.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
2.6 | 18.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
2.6 | 33.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
2.6 | 5.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
2.4 | 2.4 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
2.4 | 75.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
2.4 | 62.0 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
2.4 | 18.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
2.4 | 21.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
2.3 | 25.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
2.3 | 20.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
2.3 | 27.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
2.2 | 6.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
2.2 | 24.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
2.2 | 6.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
2.2 | 71.5 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
2.2 | 34.5 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
2.1 | 19.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.1 | 94.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
2.1 | 47.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
2.1 | 19.0 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
2.1 | 21.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
2.1 | 8.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
2.1 | 39.6 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
2.1 | 26.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
2.0 | 2.0 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
2.0 | 22.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
2.0 | 40.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
2.0 | 2.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
2.0 | 47.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
2.0 | 88.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.9 | 11.4 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.9 | 7.6 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.9 | 9.4 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.9 | 1.9 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.9 | 26.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.9 | 14.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
1.9 | 7.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.9 | 7.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
1.8 | 20.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.8 | 5.5 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
1.8 | 53.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.8 | 20.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.8 | 121.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.8 | 128.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.8 | 1.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.8 | 1.8 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
1.8 | 7.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.8 | 44.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
1.8 | 21.2 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.7 | 10.4 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
1.7 | 15.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.7 | 13.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.7 | 25.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.7 | 6.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.7 | 45.7 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.7 | 20.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
1.7 | 15.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
1.7 | 25.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.7 | 23.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
1.6 | 9.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.6 | 11.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.6 | 14.6 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
1.6 | 11.3 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
1.6 | 94.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.6 | 39.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.6 | 19.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
1.6 | 12.6 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.6 | 70.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.6 | 15.6 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
1.5 | 13.9 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.5 | 24.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.5 | 40.0 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.5 | 41.4 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
1.5 | 24.5 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.5 | 16.5 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.5 | 28.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.5 | 16.3 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.5 | 19.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
1.5 | 19.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.5 | 2.9 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.5 | 14.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.5 | 13.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.4 | 34.8 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.4 | 1.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.4 | 24.5 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
1.4 | 10.0 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
1.4 | 35.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
1.4 | 7.1 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
1.4 | 51.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.4 | 54.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
1.4 | 2.8 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.4 | 19.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
1.4 | 34.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
1.4 | 6.9 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
1.4 | 17.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
1.4 | 30.1 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.4 | 53.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.4 | 12.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
1.3 | 5.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
1.3 | 2.6 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
1.3 | 46.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
1.3 | 30.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
1.3 | 7.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
1.3 | 163.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
1.3 | 6.3 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
1.2 | 27.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
1.2 | 5.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.2 | 3.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
1.2 | 12.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.2 | 16.0 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
1.2 | 15.1 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
1.2 | 19.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
1.1 | 21.6 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
1.1 | 5.6 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
1.1 | 10.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.1 | 17.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.1 | 5.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
1.1 | 11.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.1 | 27.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.1 | 9.7 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.1 | 15.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
1.0 | 2.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.0 | 27.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.0 | 4.0 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
1.0 | 8.0 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.0 | 56.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.0 | 8.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.0 | 4.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
1.0 | 8.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.9 | 5.7 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.9 | 7.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.9 | 6.6 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.9 | 4.6 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.9 | 15.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.9 | 26.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.9 | 13.0 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.9 | 1.8 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.9 | 21.1 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.9 | 20.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.9 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.9 | 11.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.9 | 9.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.9 | 35.2 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.9 | 7.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.9 | 7.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.9 | 4.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.9 | 1.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.9 | 11.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.8 | 18.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.8 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.8 | 72.2 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.8 | 27.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.8 | 1.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.8 | 21.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.8 | 6.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.8 | 15.0 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.8 | 8.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.8 | 3.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.8 | 13.0 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.7 | 83.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.7 | 14.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.7 | 65.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.7 | 4.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.7 | 1.5 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.7 | 2.9 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.7 | 16.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.7 | 5.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.7 | 2.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.7 | 2.1 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.7 | 6.7 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.7 | 0.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.7 | 8.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.6 | 1.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.6 | 26.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 6.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 11.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.6 | 1.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.6 | 7.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.6 | 1.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.6 | 0.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.6 | 14.2 | REACTOME TRANSLATION | Genes involved in Translation |
0.6 | 2.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.6 | 4.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.6 | 8.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 3.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 3.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.5 | 1.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.5 | 9.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 4.7 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.5 | 6.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.5 | 1.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.5 | 18.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 14.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.5 | 7.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.5 | 1.5 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.5 | 5.6 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.5 | 0.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.5 | 10.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.4 | 3.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.4 | 1.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.4 | 11.9 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.4 | 10.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.4 | 13.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 4.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 23.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.4 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 5.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.4 | 1.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 3.1 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 26.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.3 | 19.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 3.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 2.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.3 | 13.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.3 | 3.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.2 | 4.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.2 | 3.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 1.5 | REACTOME OPSINS | Genes involved in Opsins |
0.2 | 5.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.3 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.2 | 0.3 | REACTOME TRANSCRIPTION COUPLED NER TC NER | Genes involved in Transcription-coupled NER (TC-NER) |
0.2 | 0.5 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.2 | 3.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.2 | 2.1 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.2 | 5.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 0.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.3 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 7.5 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.5 | REACTOME DEFENSINS | Genes involved in Defensins |
0.1 | 1.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 0.2 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 1.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.3 | REACTOME METABOLISM OF PROTEINS | Genes involved in Metabolism of proteins |
0.0 | 0.0 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |